Search:
Tokushima University > Graduate School of Medical Sciences > Medical Science > Molecular Medicine >
Tokushima University > Research Clusters > Research Clusters (Specified) > 2001004 統合的がん研究創薬クラスター∼多段階発がん関連分子を標的とした中分子創薬の開発∼ >
(Files for researchmap) [PDF manual] [Auto-propagate to researchmap]

Research Activity

His Web Page

Field of Study

分子腫瘍学

Subject of Study

ヒトゲノム情報解析による癌関連遺伝子の同定・機能解析・癌化機構の解明および臨床応用可能な創薬研究

Book / Paper

Book:

1. Tetsuro Yoshimaru and Toyomasa Katagiri :
乳がんにおける新規がん抑制因子不活化機構の解明と創薬研究,
Sep. 2018.

Academic Paper (Judged Full Paper):

1. Kazuyoshi Ishigaki, Masato Akiyama, Masahiro Kanai, Atsushi Takahashi, Eiryo Kawakami, Hiroki Sugishita, Saori Sakaue, Nana Matoba, Siew-Kee Low, Yukinori Okada, Chikashi Terao, Tiffany Amariuta, Steven Gazal, Yuta Kochi, Momoko Horikoshi, Ken Suzuki, Kaoru Ito, Satoshi Koyama, Kouichi Ozaki, Shumpei Niida, Yasushi Sakata, Yasuhiko Sakata, Takashi Kohno, Kouya Shiraishi, Yukihide Momozawa, Makoto Hirata, Koichi Matsuda, Masashi Ikeda, Nakao Iwata, Shiro Ikegawa, Ikuyo Kou, Toshihiro Tanaka, Hidewaki Nakagawa, Akari Suzuki, Tomomitsu Hirota, Mayumi Tamari, Kazuaki Chayama, Daiki Miki, Masaki Mori, Satoshi Nagayama, Yataro Daigo, Yoshio Miki, Toyomasa Katagiri, Osamu Ogawa, Wataru Obara, Hidemi Ito, Teruhiko Yoshida, Issei Imoto, Takashi Takahashi, Chizu Tanikawa, Takao Suzuki, Nobuaki Sinozaki, Shiro Minami, Hiroki Yamaguchi, Satoshi Asai, Yasuo Takahashi, Ken Yamaji, Kazuhisa Takahashi, Tomoaki Fujioka, Ryo Takata, Hideki Yanai, Akihide Masumoto, Yukihiro Koretsune, Hiromu Kutsumi, Masahiko Higashiyama, Shigeo Murayama, Naoko Minegishi, Kichiya Suzuki, Kozo Tanno, Atsushi Shimizu, Taiki Yamaji, Motoki Iwasaki, Norie Sawada, Hirokazu Uemura, Keitaro Tanaka, Mariko Naito, Makoto Sasaki, Kenji Wakai, Shoichiro Tsugane, Masayuki Yamamoto, Kazuhiko Yamamoto, Yoshinori Murakami, Yusuke Nakamura, Soumya Raychaudhuri, Johji Inazawa, Toshimasa Yamauchi, Takashi Kadowaki, Michiaki Kubo and Yoichiro Kamatani :
Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases.,
Nature Genetics, Vol.52, No.7, 669-679, 2020.
(DOI: 10.1038/s41588-020-0640-3,   PubMed: 32514122)
2. Yukie Fujimoto, Natsuko Inoue, Koji Morimoto, Takahiro Watanabe, Seiichi Hirota, Michiko Imamura, Yosuke Matsushita, Toyomasa Katagiri, Haruki Okamura and Yasuo Miyoshi :
Significant association between high serum CCL5 levels and better disease-free survival of patients with early breast cancer.,
Cancer Science, Vol.111, No.1, 209-218, 2019.
(Tokushima University Institutional Repository: 114897,   DOI: 10.1111/cas.14234,   PubMed: 31724785)
3. Ryuichiro Kimura, Tetsuro Yoshimaru, Yosuke Matsushita, Taisuke Matsuo, Masaya Ono, Jae-Hyun Park, Mitsunori Sasa, Yasuo Miyoshi, Yusuke Nakamura and Toyomasa Katagiri :
The GALNT6‑LGALS3BP axis promotes breast cancer cell growth.,
International Journal of Oncology, Vol.56, No.2, 581-595, 2019.
(DOI: 10.3892/ijo.2019.4941,   PubMed: 31894262)
4. Izumi Ohigashi, Yu Tanaka, Kenta Kondou, Sayumi Fujimori, Hiroyuki Kondo, Amy Palin, Victoria Hoffmann, Mina Kozai, Yosuke Matsushita, Shinsuke Uda, Ryo Motosugi, Jun Hamazaki, Hiroyuki Kubota, Shigeo Murata, Keiji Tanaka, Toyomasa Katagiri, Hidetaka Kosako and Yousuke Takahama :
Trans-omics Impact of Thymoproteasome in Cortical Thymic Epithelial Cells.,
Cell Reports, Vol.29, No.9, 2901-2916.e6, 2019.
(Tokushima University Institutional Repository: 115049,   DOI: 10.1016/j.celrep.2019.10.079,   PubMed: 31775054)
5. Siew-Kee Low, Ming Yoon Chin, Hidemi Ito, Keitaro Matsuo, Chizu Tanikawa, Koichi Matsuda, Hiroko Saito, Mika Sakurai-Yageta, Naoki Nakaya, Atsushi Shimizu, S Satoshi Nishizuka, Taiki Yamaji, Norie Sawada, Motoki Iwasaki, Shoichiro Tsugane, Toshiro Takezaki, Sadao Suzuki, Mariko Naito, Kenji Wakai, Yoichiro Kamatani, Yukihide Momozawa, Yoshinori Murakami, Johji Inazawa, Yusuke Nakamura, Michiaki Kubo, Toyomasa Katagiri and Yoshio Miki :
Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population.,
Scientific Reports, Vol.9, No.1, 17332, 2019.
(Tokushima University Institutional Repository: 114954,   DOI: 10.1038/s41598-019-53654-9,   PubMed: 31757997)
6. Natsuko Inoue, Wen Li, Yukie Fujimoto, Yosuke Matsushita, Toyomasa Katagiri, Haruki Okamura and Yasuo Miyoshi :
High Serum Levels of Interleukin-18 Are Associated With Worse Outcomes in Patients With Breast Cancer.,
Anticancer Research, Vol.39, No.9, 5009-5018, 2019.
(DOI: 10.21873/anticanres.13691,   PubMed: 31519608)
7. Takeru Chigira, Satoru Nagatoishi, Hiroyuki Takeda, Tetsuro Yoshimaru, Toyomasa Katagiri and Kouhei Tsumoto :
Biophysical characterization of the breast cancer-related BIG3-PHB2 interaction: Effect of non-conserved loop region of BIG3 on the structure and the interaction.,
Biochemical and Biophysical Research Communications, Vol.518, No.1, 183-189, 2019.
(DOI: 10.1016/j.bbrc.2019.08.028,   PubMed: 31421830)
8. Yukihide Momozawa, Yusuke Iwasaki, T Michael Parsons, Yoichiro Kamatani, Atsushi Takahashi, Chieko Tamura, Toyomasa Katagiri, Teruhiko Yoshida, Seigo Nakamura, Kokichi Sugano, Yoshio Miki, Makoto Hirata, Koichi Matsuda, B Amanda Spurdle and Michiaki Kubo :
Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls.,
Nature Communications, Vol.9, No.1, 2018.
(DOI: 10.1038/s41467-018-06581-8,   PubMed: 30287823,   Elsevier: Scopus)
9. Boya Deng, Emre Yunus Tarhan, Koji Ueda, Lili Ren, Toyomasa Katagiri, Jae-Hyun Park and Yusuke Nakamura :
Critical Role of Estrogen Receptor Alpha O-Glycosylation by N-Acetylgalactosaminyltransferase 6 (GALNT6) in Its Nuclear Localization in Breast Cancer Cells.,
Neoplasia, Vol.20, No.10, 1038-1044, 2018.
(DOI: 10.1016/j.neo.2018.08.006,   PubMed: 30208353)
10. Yoichiro Kato, Hitoshi Zembutsu, Ryo Takata, Tomohiko Matsuura, Renpei Kato, Mitsugu Kanehira, Kazuhiro Iwasaki, Noriyuki Yamada, Toyomasa Katagiri, Tamotsu Sugai, Tomoaki Fujioka, Yusuke Nakamura and Wataru Obara :
A prospective study to examine the accuracies and efficacies of prediction systems for response to neoadjuvant chemotherapy for muscle invasive bladder cancer.,
Oncology Letters, Vol.16, No.5, 5775-5784, 2018.
(DOI: 10.3892/ol.2018.9330,   PubMed: 30333861)
11. Keiko Huizi Li, Aya Sugyo, B Atsushi Tsuji, Yukie Morokoshi, Katsuyuki Minegishi, Kotaro Nagatsu, Hiroaki Kanda, Yosuke Harada, Satoshi Nagayama, Toyomasa Katagiri, Yusuke Nakamura, Tatsuya Higashi and Sumitaka Hasegawa :
α-particle therapy for synovial sarcoma in the mouse using an astatine-211-labeled antibody against frizzled homolog 10.,
Cancer Science, Vol.109, No.7, 2302-2309, 2018.
(Tokushima University Institutional Repository: 112381,   DOI: 10.1111/cas.13636,   PubMed: 29952132)
12. Anne-Laure Giraudet, Alexandre Philippe Cassier, Chicaco Iwao-Fukukawa, Gwenaelle Garin, Jean-Noël Badel, David Kryza, Sylvie Chabaud, Laurence Gilles-Afchain, Gilles Clapisson, Claude Desuzinges, David Sarrut, Adrien Halty, Antoine Italiano, Masaharu Mori, Takuya Tsunoda, Toyomasa Katagiri, Yusuke Nakamura, Laurent Alberti, Claire Cropet, Simon Baconnier, Sandrine Berge-Montamat, David Pérol and Jean-Yves Blay :
A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients.,
BMC Cancer, Vol.18, No.1, 646, 2018.
(Tokushima University Institutional Repository: 114362,   DOI: 10.1186/s12885-018-4544-x,   PubMed: 29884132)
13. Kei Daizumoto, Tetsuro Yoshimaru, Yosuke Matsushita, Tomoya Fukawa, Hisanori Uehara, Masaya Ono, Masato Komatsu, Hiro-omi Kanayama and Toyomasa Katagiri :
A DDX31/mutant-p53/EGFR axis promotes multistep progression of muscle invasive bladder cancer,
Cancer Research, Vol.78, No.9, 2233-2247, 2018.
(Tokushima University Institutional Repository: 111804,   DOI: 10.1158/0008-5472.CAN-17-2528,   PubMed: 29440146)
14. Yoshimasa Miyagawa, Yosuke Matsushita, Hiromu Suzuki, Masato Komatsu, Tetsuro Yoshimaru, Ryuichiro Kimura, Ayako Yanai, Junko Honda, Akira Tangoku, Mitsunori Sasa, Yasuo Miyoshi and Toyomasa Katagiri :
Frequent downregulation of LRRC26 by epigenetic alterations is involved in the malignant progression of triple-negative breast cancer.,
International Journal of Oncology, 2018.
(DOI: 10.3892/ijo.2018.4301,   PubMed: 29512727)
15. Wataru Obara, Mitsugu Kanehira, Toyomasa Katagiri, Renpei Kato, Yoichiro Kato and Ryo Takata :
Present status and future perspective of peptide-based vaccine therapy for urological cancer.,
Cancer Science, Vol.109, No.3, 550-559, 2018.
(Tokushima University Institutional Repository: 112379,   DOI: 10.1111/cas.13506,   PubMed: 29345737)
16. Shoki Sato, Toru Nakamura, Toyomasa Katagiri, Takahiro Tsuchikawa, Toshihiro Kushibiki, Kouji Hontani, Mizuna Takahashi, Kazuho Inoko, Hironobu Takano, Hirotake Abe, Shintaro Takeuchi, Masato Ono, Shota Kuwabara, Kazufumi Umemoto, Tomohiro Suzuki, Osamu Sato, Yusuke Nakamura and Satoshi Hirano :
Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation.,
Oncotarget, Vol.8, No.69, 113662-113672, 2017.
(Tokushima University Institutional Repository: 113052,   DOI: 10.18632/oncotarget.21939,   PubMed: 29371937)
17. Arisa Nishimukai, Natsuko Inoue, Ayako Kira, Masashi Takeda, Koji Morimoto, Kazuhiro Araki, Kazuhiro Kitajima, Takahiro Watanabe, Seiichi Hirota, Toyomasa Katagiri, Shoji Nakamori, Kouhei Akazawa and Yasuo Miyoshi :
Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers.,
PLoS ONE, Vol.12, No.9, 2017.
(Tokushima University Institutional Repository: 112344,   DOI: 10.1371/journal.pone.0184508,   PubMed: 28886153,   Elsevier: Scopus)
18. Tetsuro Yoshimaru, Masaya Ono, Yoshimi Bando, Yi-An Chen, Kenji Mizuguchi, Hiroshi Shima, Masato Komatsu, Issei Imoto, Keisuke Izumi, Junko Honda, Yasuo Miyoshi, Mitsunori Sasa and Toyomasa Katagiri :
A-kinase anchoring protein BIG3 coordinates oestrogen signalling in breast cancer cells.,
Nature Communications, Vol.8, 2017.
(Tokushima University Institutional Repository: 112449,   DOI: 10.1038/ncomms15427,   PubMed: 28555617)
19. Daichi Shigemizu, Takuji Iwase, Masataka Yoshimoto, Yasuyo Suzuki, Fuyuki Miya, A Keith Boroevich, Toyomasa Katagiri, Hitoshi Zembutsu and Tatsuhiko Tsunoda :
The prediction models for postoperative overall survival and disease-free survival in patients with breast cancer.,
Cancer Medicine, Vol.6, No.7, 1627-1638, 2017.
(Tokushima University Institutional Repository: 115038,   DOI: 10.1002/cam4.1092,   PubMed: 28544536)
20. Tetsuro Yoshimaru, Keisuke Aihara, Masato Komatsu, Yosuke Matsushita, Yasumasa Okazaki, Shinya Toyokuni, Junko Honda, Mitsunori Sasa, Yasuo Miyoshi, Akira Otaka and Toyomasa Katagiri :
Stapled BIG3 helical peptide ERAP potentiates anti-tumour activity for breast cancer therapeutics.,
Scientific Reports, Vol.7, No.1, 1821, 2017.
(Tokushima University Institutional Repository: 112387,   DOI: 10.1038/s41598-017-01951-6,   PubMed: 28500289)
21. Yuki Shikata, Tetsuro Yoshimaru, Masato Komatsu, Hiroto Katoh, Reiko Sato, Shuhei Kanagaki, Yasumasa Okazaki, Shinya Toyokuni, Etsu Tashiro, Shumpei Ishikawa, Toyomasa Katagiri and Masaya Imoto :
Protein kinase A inhibition facilitates the antitumor activity of xanthohumol, a valosin-containing protein inhibitor.,
Cancer Science, Vol.108, No.4, 785-794, 2017.
(Tokushima University Institutional Repository: 112374,   DOI: 10.1111/cas.13175,   PubMed: 28122154)
22. Takayuki Iwamoto, Toyomasa Katagiri, Naoki Niikura, Yuichiro Miyoshi, Mariko Kochi, Tomohiro Nogami, Tadahiko Shien, Takayuki Motoki, Naruto Taira, Masako Omori, Yutaka Tokuda, Toshiyoshi Fujiwara, Hiroyoshi Doihara, Balazs Gyorffy and Junji Matsuoka :
Immunohistochemical Ki67 after short-term hormone therapy identifies low-risk breast cancers as reliably as genomic markers.,
Oncotarget, Vol.8, No.16, 26122-26128, 2017.
(Tokushima University Institutional Repository: 113050,   DOI: 10.18632/oncotarget.15385,   PubMed: 28412725)
23. Yasuhiro Uno, Ryo Takata, Go Kito, Hiroshi Yamazaki, Kazuko Nakagawa, Yusuke Nakamura, Tetsuya Kamataki and Toyomasa Katagiri :
Sex- and age-dependent gene expression in human liver: An implication for drug-metabolizing enzymes.,
Drug Metabolism and Pharmacokinetics, Vol.32, No.1, 100-107, 2016.
(DOI: 10.1016/j.dmpk.2016.10.409,   PubMed: 28153492)
24. Wataru Obara, Takashi Karashima, Kazuyoshi Takeda, Renpei Kato, Yoichiro Kato, Mitsugu Kanehira, Ryo Takata, Keiji Inoue, Toyomasa Katagiri, Taro Shuin, Yusuke Nakamura and Tomoaki Fujioka :
Effective induction of cytotoxic T cells recognizing an epitope peptide derived from hypoxia-inducible protein 2 (HIG2) in patients with metastatic renal cell carcinoma.,
Cancer Immunology, Immunotherapy, Vol.66, No.1, 17-24, 2016.
(Tokushima University Institutional Repository: 115034,   DOI: 10.1007/s00262-016-1915-5,   PubMed: 27757561,   Elsevier: Scopus)
25. Toru Nakamura, Toyomasa Katagiri, Shoki Sato, Toshihiro Kushibiki, Koji Hontani, Takahiro Tsuchikawa, Satoshi Hirano and Yusuke Nakamura :
Overexpression of C16orf74 is involved in aggressive pancreatic cancers.,
Oncotarget, Vol.8, No.31, 50460-50475, 2016.
(Tokushima University Institutional Repository: 113051,   DOI: 10.18632/oncotarget.10912,   PubMed: 28881575)
26. Jae-Hyun Park, Miran Jang, Emre Yunus Tarhan, Toyomasa Katagiri, Mitsunori Sasa, Yasuo Miyoshi, R Krishna Kalari, J Vera Suman, Richard Weinshilboum, Liewei Wang, C Judy Boughey, P Matthew Goetz and Yusuke Nakamura :
Clonal expansion of antitumor T cells in breast cancer correlates with response to neoadjuvant chemotherapy.,
International Journal of Oncology, Vol.49, No.2, 471-478, 2016.
(DOI: 10.3892/ijo.2016.3540,   PubMed: 27278091)
27. Michiko Imamura, Arisa Nishimukai, Tomoko Higuchi, Hiromi Ozawa, Ayako Yanai, Yoshimasa Miyagawa, Keiko Murase, Isao Sakita, Takuya Hatada, Yuichi Takatsuka, Toyomasa Katagiri and Yasuo Miyoshi :
High levels at baseline of serum pyridinoline crosslinked carboxyterminal telopeptide of type I collagen are associated with worse prognosis for breast cancer patients.,
Breast Cancer Research and Treatment, Vol.154, No.3, 521-531, 2015.
(DOI: 10.1007/s10549-015-3638-2,   PubMed: 26573829)
28. Namhee Kim, Tetsuro Yoshimaru, Yi-An Chen, Taisuke Matsuo, Masato Komatsu, Yasuo Miyoshi, Eiji Tanaka, Mitsunori Sasa, Kenji Mizuguchi and Toyomasa Katagiri :
BIG3 Inhibits the Estrogen-Dependent Nuclear Translocation of PHB2 via Multiple Karyopherin-Alpha Proteins in Breast Cancer Cells.,
PLoS ONE, Vol.10, No.6, 2015.
(Tokushima University Institutional Repository: 109497,   DOI: 10.1371/journal.pone.0127707,   PubMed: 26052702,   Elsevier: Scopus)
29. Tetsuro Yoshimaru, Masato Komatsu, Yasuo Miyoshi, Junko Honda, Mitsunori Sasa and Toyomasa Katagiri :
Therapeutic advances in BIG3-PHB2 inhibition targeting the crosstalk between estrogen and growth factors in breast cancer.,
Cancer Science, Vol.106, No.5, 550-558, 2015.
(DOI: 10.1111/cas.12654,   PubMed: 25736224,   Elsevier: Scopus)
30. Ayako Yanai, Natsuko Inoue, Tomoko Yagi, Arisa Nishimukai, Yoshimasa Miyagawa, Keiko Murase, Michiko Imamura, Yukie Enomoto, Yuichi Takatsuka, Takahiro Watanabe, Seiichi Hirota, Mitsunori Sasa, Toyomasa Katagiri and Yasuo Miyoshi :
Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER(+), and HER2(-) Breast Cancer.,
Clinical Breast Cancer, Vol.15, No.3, 197-203, 2014.
(DOI: 10.1016/j.clbc.2014.12.002,   PubMed: 25600244)
31. Tetsuro Yoshimaru, Masato Komatsu, Etsu Tashiro, Masaya Imoto, Hiroyuki Osada, Yasuo Miyoshi, Junko Honda, Mitsunoi Sasa and Toyomasa Katagiri :
Xanthohumol suppresses oestrogen-signalling in breast cancer through the inhibition of BIG3-PHB2 interactions.,
Scientific Reports, Vol.4, 7355, 2014.
(DOI: 10.1038/srep07355,   PubMed: 25483453)
32. Taisuke Matsuo, Le Tan Dat, Masato Komatsu, Tetsuro Yoshimaru, Kei Daizumoto, Saburo Sone, Yasuhiko Nishioka and Toyomasa Katagiri :
Early growth response 4 is involved in cell proliferation of small cell lung cancer through transcriptional activation of its downstream genes.,
PLoS ONE, Vol.9, No.11, e113606, 2014.
(DOI: 10.1371/journal.pone.0113606,   PubMed: 25411851,   Elsevier: Scopus)
33. Yi Paulisally Hau Lo, Chizu Tanikawa, Toyomasa Katagiri, Yusuke Nakamura and Koichi Matsuda :
Identification of novel epigenetically inactivated gene PAMR1 in breast carcinoma.,
Oncology Reports, Vol.33, No.1, 267-273, 2014.
(DOI: 10.3892/or.2014.3581,   PubMed: 25370079)
34. Yi-An Chen, Yoichi Murakami, Shandar Ahmad, Tetsuro Yoshimaru, Toyomasa Katagiri and Kenji Mizuguchi :
Brefeldin A-inhibited guanine nucleotide-exchange protein 3 (BIG3) is predicted to interact with its partner through an ARM-type -helical structure.,
BMC Research Notes, Vol.7, No.1, 435, 2014.
(Tokushima University Institutional Repository: 114782,   DOI: 10.1186/1756-0500-7-435,   PubMed: 24997568)
35. Sachiko Yoshimura, Takuya Tsunoda, Ryuji Osawa, Makiko Harada, Tomohisa Watanabe, Tetsuro Hikichi, Masahiro Katsuda, Motoki Miyazawa, Masaji Tani, Makoto Iwahashi, Kazuyoshi Takeda, Toyomasa Katagiri, Yusuke Nakamura and Hiroki Yamaue :
Identification of an HLA-A2-restricted epitope peptide derived from hypoxia-inducible protein 2 (HIG2).,
PLoS ONE, Vol.9, No.1, e85267, 2014.
(DOI: 10.1371/journal.pone.0085267,   PubMed: 24416375,   Elsevier: Scopus)
36. Taisuke Matsuo, Masato Komatsu, Tetsuro Yoshimaru, Kazuma Kiyotani, Yasuo Miyoshi, Mitsunori Sasa and Toyomasa Katagiri :
Involvement of B3GALNT2 overexpression in the cell growth of breast cancer.,
International Journal of Oncology, Vol.44, No.2, 427-434, 2013.
(DOI: 10.3892/ijo.2013.2187,   PubMed: 24285400,   Elsevier: Scopus)
37. Siew-Kee Low, Atsushi Takahashi, Kyota Ashikawa, Johji Inazawa, Yoshio Miki, Michiaki Kubo, Yusuke Nakamura and Toyomasa Katagiri :
Genome-wide association study of breast cancer in the Japanese population.,
PLoS ONE, Vol.8, No.10, 2013.
(DOI: 10.1371/journal.pone.0076463,   PubMed: 24143190)
38. Ayako Yanai, Yoshimasa Miyagawa, Keiko Murase, Michiko Imamura, Tomoko Yagi, Shigetoshi Ichii, Yuichi Takatsuka, Takashi Ito, Seiichi Hirota, Mitsunori Sasa, Toyomasa Katagiri and Yasuo Miyoshi :
Influence of body mass index on clinicopathological factors including estrogen receptor, progesterone receptor, and Ki67 expression levels in breast cancers.,
International Journal of Clinical Oncology, Vol.19, No.3, 467-472, 2013.
(DOI: 10.1007/s10147-013-0585-y,   PubMed: 23821234)
39. Masato Komatsu, Tetsuro Yoshimaru, Taisuke Matsuo, Kazuma Kiyotani, Yasuo Miyoshi, Toshihito Tanahashi, Kazuhito Rokutan, Rui Yamaguchi, Ayumu Saito, Seiya Imoto, Satoru Miyano, Yusuke Nakamura, Mitsunori Sasa, Mitsuo Shimada and Toyomasa Katagiri :
Molecular features of triple negative breast cancer cells by genome-wide gene expression profiling analysis.,
International Journal of Oncology, Vol.42, No.2, 478-506, 2013.
(DOI: 10.3892/ijo.2012.1744,   PubMed: 23254957)
40. Yoichiro Kajita, Tomohisa Kato, Sakura Tamaki, Moritoshi Furu, Ryo Takahashi, Satoshi Nagayama, Tomoki Aoyama, Hiroyuki Nishiyama, Eijiro Nakamura, Toyomasa Katagiri, Yusuke Nakamura, Osamu Ogawa and Junya Toguchida :
The transcription factor Sp3 regulates the expression of a metastasis-related marker of sarcoma, actin filament-associated protein 1-like 1 (AFAP1L1).,
PLoS ONE, Vol.8, No.1, 2013.
(DOI: 10.1371/journal.pone.0049709,   PubMed: 23326307)
41. Tetsuro Yoshimaru, Masato Komatsu, Taisuke Matsuo, Yi-An Chen, Yoichi Murakami, Kenji Mizuguchi, Eiichi Mizohata, Tsuyoshi Inoue, Miki Akiyama, Rui Yamaguchi, Seiya Imoto, Satoru Miyano, Yasuo Miyoshi, Mitsunori Sasa, Yusuke Nakamura and Toyomasa Katagiri :
Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells.,
Nature Communications, Vol.4, 2443, 2013.
(DOI: 10.1038/ncomms3443,   PubMed: 24051437)
42. Kazuma Kiyotani and Toyomasa Katagiri :
A commentary on Analysis of ZNF350/ZBRK1 promoter variants and breast cancer susceptibility in non-BRCA1/2 French Canadian breast cancer families.,
Journal of Human Genetics, Vol.58, No.2, 58, 2012.
(DOI: 10.1038/jhg.2012.142,   PubMed: 23223009)
43. Tomoya Fukawa, Masaya Ono, Taisuke Matsuo, Hisanori Uehara, Tsuneharu Miki, Yusuke Nakamura, Hiro-omi Kanayama and Toyomasa Katagiri :
DDX31 regulates the p53-HDM2 pathway and rRNA gene transcription through its interaction with NPM1 in renal cell carcinomas,
Cancer Research, Vol.72, No.22, 5867-5877, 2012.
(DOI: 10.1158/0008-5472.CAN-12-1645,   PubMed: 23019224)
44. Seham Elgazzar, Hitoshi Zembutsu, Atsushi Takahashi, Michiaki Kubo, Fuminori Aki, Koichi Hirata, Yuichi Takatsuka, Minoru Okazaki, Shozo Ohsumi, Takashi Yamakawa, Mitsunori Sasa, Toyomasa Katagiri, Yoshio Miki and Yusuke Nakamura :
A genome-wide association study identifies a genetic variant in the SIAH2 locus associated with hormonal receptor-positive breast cancer in Japanese.,
Journal of Human Genetics, Vol.57, No.12, 766-771, 2012.
(DOI: 10.1038/jhg.2012.108,   PubMed: 22951594)
45. Wataru Obara, Ryuji Ohsawa, Mitsugu Kanehira, Ryo Takata, Takuya Tsunoda, Koji Yoshida, Kazuyoshi Takeda, Toyomasa Katagiri, Yusuke Nakamura and Tomoaki Fujioka :
Cancer Peptide Vaccine Therapy Developed from Oncoantigens Identified through Genome-wide Expression Profile Analysis for Bladder Cancer.,
Japanese Journal of Clinical Oncology, Vol.42, No.7, 591-600, 2012.
(DOI: 10.1093/jjco/hys069,   PubMed: 22636067)
46. Keiko Murase, Ayako Yanai, Masaru Saito, Michiko Imamura, Yoshimasa Miyagawa, Yuichi Takatsuka, Natsuko Inoue, Takashi Ito, Seiichi Hirota, Mitsunori Sasa, Toyomasa Katagiri, Yasuhisa Fujimoto, Takuya Hatada, Shigetoshi Ichii, Tomoyuki Nishizaki, Naohiro Tomita and Yasuo Miyoshi :
Biological characteristics of luminal subtypes in pre- and postmenopausal estrogen receptor-positive and HER2-negative breast cancers.,
Breast Cancer, Vol.21, No.1, 52-57, 2012.
(DOI: 10.1007/s12282-012-0348-z,   PubMed: 22359195)
47. Le T Dat, Taisuke Matsuo, Tetsuro Yoshimaru, Souji Kakiuchi, Hisatsugu Goto, Masaki Hanibuchi, Takuya Kuramoto, Yasuhiko Nishioka, Saburo Sone and Toyomasa Katagiri :
Identification of genes potentially involved in bone metastasis by genome-wide gene expression profile analysis of non-small cell lung cancer in mice,
International Journal of Oncology, Vol.40, No.5, 1455-1469, 2012.
(DOI: 10.3892/ijo.2012.1348,   PubMed: 22294041)
48. Hiroki Yoshioka, Shinji Yamamoto, Hirofumi Hanaoka, Yasuhiko Iida, Pramila Paudyal, Tetsuya Higuchi, Hideyuki Tominaga, Noboru Oriuchi, Hidewaki Nakagawa, Yasuhiro Shiba, Koji Yoshida, Ryuji Osawa, Toyomasa Katagiri, Takuya Tsunoda, Yusuke Nakamura and Keigo Endo :
In vivo therapeutic effect of CDH3/P-cadherin-targeting radioimmunotherapy.,
Cancer Immunology, Immunotherapy, Vol.61, No.8, 1211-1220, 2012.
(DOI: 10.1007/s00262-011-1186-0,   PubMed: 22223257)
49. Takeaki Kawai, M Jose M Caaveiro, Ryota Abe, Toyomasa Katagiri and Kouhei Tsumoto :
Catalytic activity of MsbA reconstituted in nanodisc particles is modulated by remote interactions with the bilayer.,
FEBS Letters, Vol.585, No.22, 3533-3537, 2011.
(DOI: 10.1016/j.febslet.2011.10.015,   PubMed: 22020218)
50. M Furu, Y Kajita, S Nagayama, T Ishibe, Y Shima, K Nishijo, D Uejima, R Takahashi, T Aoyama, T Nakayama, T Nakamura, Y Nakashima, M Ikegawa, S Imoto, Toyomasa Katagiri, Y Nakamura and J Toguchida :
Identification of AFAP1L1 as a prognostic marker for spindle cell sarcomas.,
Oncogene, Vol.30, No.38, 4015-4025, 2011.
(DOI: 10.1038/onc.2011.108,   PubMed: 21516130)
51. Jae-Hyun Park, Toyomasa Katagiri, Suyoun Chung, Kyoko Kijima and Yusuke Nakamura :
Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin.,
Neoplasia, Vol.13, No.4, 320-326, 2011.
(DOI: 10.1593/neo.101440,   PubMed: 21472136)
52. Masahiko Ajiro, Toshihiko Nishidate, Toyomasa Katagiri and Yusuke Nakamura :
Critical involvement of RQCD1 in the EGFR-Akt pathway in mammary carcinogenesis.,
International Journal of Oncology, Vol.37, No.5, 1085-1093, 2010.
(DOI: 10.3892/ijo_00000760,   PubMed: 20878056)
53. Chikako Fukukawa, Koji Ueda, Toshihiko Nishidate, Toyomasa Katagiri and Yusuke Nakamura :
Critical roles of LGN/GPSM2 phosphorylation by PBK/TOPK in cell division of breast cancer cells.,
Genes, Chromosomes & Cancer, Vol.49, No.10, 861-872, 2010.
(DOI: 10.1002/gcc.20795,   PubMed: 20589935)
54. Jung-Won Kim, Chikako Fukukawa, Koji Ueda, Toshihiko Nishidate, Toyomasa Katagiri and Yusuke Nakamura :
Involvement of C12orf32 overexpression in breast carcinogenesis.,
International Journal of Oncology, Vol.37, No.4, 861-867, 2010.
(DOI: 10.3892/ijo_00000737,   PubMed: 20811708)
55. Yosuke Harada, Mitsugu Kanehira, Yoshiko Fujisawa, Ryo Takata, Taro Shuin, Tsuneharu Miki, Tomoaki Fujioka, Yusuke Nakamura and Toyomasa Katagiri :
Cell-permeable peptide DEPDC1-ZNF224 interferes with transcriptional repression and oncogenicity in bladder cancer cells.,
Cancer Research, Vol.70, No.14, 5829-5839, 2010.
(DOI: 10.1158/0008-5472.CAN-10-0255,   PubMed: 20587513)
56. Jae-Hyun Park, Toshihiko Nishidate, Kyoko Kijima, Takao Ohashi, Kaoru Takegawa, Tomoko Fujikane, Koichi Hirata, Yusuke Nakamura and Toyomasa Katagiri :
Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis.,
Cancer Research, Vol.70, No.7, 2759-2769, 2010.
(DOI: 10.1158/0008-5472.CAN-09-3911,   PubMed: 20215525)
57. Tomomi Ueki, Jae-Hyun Park, Toshihiko Nishidate, Kyoko Kijima, Koichi Hirata, Yusuke Nakamura and Toyomasa Katagiri :
Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells.,
Cancer Research, Vol.69, No.22, 8752-8760, 2009.
(DOI: 10.1158/0008-5472.CAN-09-1809,   PubMed: 19887602)
58. Jae-Hyun Park, Toshihiko Nishidate, Yusuke Nakamura and Toyomasa Katagiri :
Critical roles of T-LAK cell-originated protein kinase in cytokinesis.,
Cancer Science, Vol.101, No.2, 403-411, 2009.
(DOI: 10.1111/j.1349-7006.2009.01400.x,   PubMed: 19900192)
59. Masahiko Ajiro, Toyomasa Katagiri, Koji Ueda, Hidewaki Nakagawa, Chikako Fukukawa, Meng-Lay Lin, Jae-Hyun Park, Toshihiko Nishidate, Yataro Daigo and Yusuke Nakamura :
Involvement of RQCD1 overexpression, a novel cancer-testis antigen, in the Akt pathway in breast cancer cells.,
International Journal of Oncology, Vol.35, No.4, 673-681, 2009.
(DOI: 10.3892/ijo_00000379,   PubMed: 19724902)
60. Jung-Won Kim, Miki Akiyama, Jae-Hyun Park, Meng-Lay Lin, Arata Shimo, Tomomi Ueki, Yataro Daigo, Tatsuhiko Tsunoda, Toshihiko Nishidate, Yusuke Nakamura and Toyomasa Katagiri :
Activation of an estrogen/estrogen receptor signaling by BIG3 through its inhibitory effect on nuclear transport of PHB2/REA in breast cancer.,
Cancer Science, Vol.100, No.8, 1468-1478, 2009.
(DOI: 10.1111/j.1349-7006.2009.01209.x,   PubMed: 19496786)
61. Meng-Lay Lin, Chikako Fukukawa, Jae-Hyun Park, Kie Naito, Kyoko Kijima, Arata Shimo, Masahiko Ajiro, Toshihiko Nishidate, Yusuke Nakamura and Toyomasa Katagiri :
Involvement of G-patch domain containing 2 overexpression in breast carcinogenesis.,
Cancer Science, Vol.100, No.8, 1443-1450, 2009.
(DOI: 10.1111/j.1349-7006.2009.01185.x,   PubMed: 19432882)
62. Hirofumi Hanaoka, Toyomasa Katagiri, Chikako Fukukawa, Hiroki Yoshioka, Shinji Yamamoto, Yasuhiko Iida, Tetsuya Higuchi, Noboru Oriuchi, Bishnuhari Paudyal, Pramila Paudyal, Yusuke Nakamura and Keigo Endo :
Radioimmunotherapy of solid tumors targeting a cell-surface protein, FZD10: therapeutic efficacy largely depends on radiosensitivity.,
Annals of Nuclear Medicine, Vol.23, No.5, 479-485, 2009.
(DOI: 10.1007/s12149-009-0265-1,   PubMed: 19412654)
63. Kazuhito Morioka, Chizu Tanikawa, Kensuke Ochi, Yataro Daigo, Toyomasa Katagiri, Hirotaka Kawano, Hiroshi Kawaguchi, Akira Myoui, Hideki Yoshikawa, Norifumi Naka, Nobuto Araki, Ikuo Kudawara, Makoto Ieguchi, Kozo Nakamura, Yusuke Nakamura and Koichi Matsuda :
Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma.,
Cancer Science, Vol.100, No.7, 1227-1233, 2009.
(DOI: 10.1111/j.1349-7006.2009.01165.x,   PubMed: 19486338)
64. Koji Ueda, Yu Fukase, Toyomasa Katagiri, Nobuhisa Ishikawa, Shinji Irie, Taka-Aki Sato, Hiroyuki Ito, Haruhiko Nakayama, Yohei Miyagi, Eiju Tsuchiya, Nobuoki Kohno, Mieko Shiwa, Yusuke Nakamura and Yataro Daigo :
Targeted serum glycoproteomics for the discovery of lung cancer-associated glycosylation disorders using lectin-coupled ProteinChip arrays.,
Proteomics, Vol.9, No.8, 2182-2192, 2009.
(DOI: 10.1002/pmic.200800374,   PubMed: 19322776)
65. C Fukukawa, Satoshi Nagayama, T Tsunoda, J Toguchida, Yusuke Nakamura and Toyomasa Katagiri :
Activation of the non-canonical Dvl-Rac1-JNK pathway by Frizzled homologue 10 in human synovial sarcoma.,
Oncogene, Vol.28, No.8, 1110-20, 2009.
(DOI: 10.1038/onc.2008.467,   PubMed: 19137009)
66. S Dobashi, Toyomasa Katagiri, Eiji Hirota, Shingo Ashida, Y Daigo, T Shuin, T Fujioka, Tuneharu Miki and Yusuke Nakamura :
Involvement of TMEM22 overexpression in the growth of renal cell carcinoma cells.,
Oncology Reports, Vol.21, No.2, 305-312, 2009.
(DOI: 10.3892/or_00000222,   PubMed: 19148500)
67. Satoshi Nagayama, Eiji Yamada, Yoshiki Kohno, Tomoki Aoyama, Chikako Fukukawa, Hajime Kubo, Go Watanabe, Toyomasa Katagiri, Yusuke Nakamura, Yoshiharu Sakai and Junya Toguchida :
Inverse correlation of the up-regulation of FZD10 expression and the activation of beta-catenin in synchronous colorectal tumors.,
Cancer Science, Vol.100, No.3, 405-412, 2008.
(DOI: 10.1111/j.1349-7006.2008.01052.x,   PubMed: 19134005)
68. Hiroyuki Inoue, Mutsunori Iga, Hayuka Nabeta, Tomoko Yokoo, Yoko Suehiro, Shinji Okano, Makoto Inoue, Hiroaki Kinoh, Toyomasa Katagiri, Koichi Takayama, Yoshikazu Yonemitsu, Mamoru Hasegawa, Yusuke Nakamura, Yoichi Nakanishi and Kenzaburo Tani :
Non-transmissible Sendai virus encoding granulocyte macrophage colony-stimulating factor is a novel and potent vector system for producing autologous tumor vaccines.,
Cancer Science, Vol.99, No.11, 2315-2326, 2008.
(DOI: 10.1111/j.1349-7006.2008.00964.x,   PubMed: 18957055,   CiNii: 10024013606)
69. T Ueki, T Nishidate, JH Park, ML Lin, Arata Shimo, Koichi Hirata, Yusuke Nakamura and Toyomasa Katagiri :
Involvement of elevated expression of multiple cell-cycle regulator, DTL/RAMP (denticleless/RA-regulated nuclear matrix associated protein), in the growth of breast cancer cells.,
Oncogene, Vol.27, No.43, 5672-83, 2008.
(DOI: 10.1038/onc.2008.186,   PubMed: 18542055)
70. R Konda, J Sugimura, F Sohma, Toyomasa Katagiri, Yusuke Nakamura and T Fujioka :
Over expression of hypoxia-inducible protein 2, hypoxia-inducible factor-1alpha and nuclear factor kappaB is putatively involved in acquired renal cyst formation and subsequent tumor transformation in patients with end stage renal failure.,
The Journal of Urology, Vol.180, No.2, 481-485, 2008.
(DOI: 10.1016/j.juro.2008.04.006,   PubMed: 18550099)
71. T Kidokoro, C Tanikawa, Y Furukawa, Toyomasa Katagiri, Yusuke Nakamura and Koichi Matsuda :
CDC20, a potential cancer therapeutic target, is negatively regulated by p53.,
Oncogene, Vol.27, No.11, 1562-71, 2008.
(DOI: 10.1038/sj.onc.1210799,   PubMed: 17873905)
72. C Fukukawa, Hirofumi Hanaoka, Satoshi Nagayama, T Tsunoda, J Toguchida, Keigo Endo, Yusuke Nakamura and Toyomasa Katagiri :
Radioimmunotherapy of human synovial sarcoma using a monoclonal antibody against FZD10.,
Cancer Science, Vol.99, No.2, 432-440, 2008.
(DOI: 10.1111/j.1349-7006.2007.00701.x,   PubMed: 18271942,   CiNii: 10024002974)
73. Arata Shimo, Chizu Tanikawa, Toshihiko Nishidate, ML Lin, Koichi Matsuda, JH Park, Tomomi Ueki, Tomohiko Ohta, Koichi Hirata, Mamoru Fukuda, Yusuke Nakamura and Toyomasa Katagiri :
Involvement of kinesin family member 2C/mitotic centromere-associated kinesin overexpression in mammary carcinogenesis.,
Cancer Science, Vol.99, No.1, 62-70, 2008.
(DOI: 10.1111/j.1349-7006.2007.00635.x,   PubMed: 17944972,   CiNii: 10024000927)
74. Yoichiro Kamatani, Koichi Matsuda, Tetsuya Ohishi, Shigeru Ohtsubo, Keiko Yamazaki, Aritoshi Iida, Naoya Hosono, Michiaki Kubo, Wako Yumura, Kosaku Nitta, Toyomasa Katagiri, Yasushi Kawaguchi, Naoyuki Kamatani and Yusuke Nakamura :
Identification of a significant association of a single nucleotide polymorphism in TNXB with systemic lupus erythematosus in a Japanese population.,
Journal of Human Genetics, Vol.53, No.1, 64-73, 2008.
(DOI: 10.1007/s10038-007-0219-1,   PubMed: 18058064,   CiNii: 10021247556)
75. K Ueda, Toyomasa Katagiri, T Shimada, S Irie, T Sato, Y Nakamura and Y Daigo :
Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer,
Journal of Proteome Research, Vol.6, No.9, 3475-83, 2007.
(DOI: 10.1021/pr070103h,   PubMed: 17705522)
76. S Senju, H Suemori, H Zembutsu, Y Uemura, S Hirata, D Fukuma, H Matsuyoshi, M Shimomura, M Haruta, S Fukushima, Y Matsunaga, Toyomasa Katagiri, Y Nakamura, M Furuya, N Nakatsuji and Y Nishimura :
Genetically manipulated human embryonic stem cell-derived dendritic cells with immune regulatory function,
Stem Cells, Vol.25, No.11, 2720-2729, 2007.
(DOI: 10.1634/stemcells.2007-0321,   PubMed: 17690179)
77. H Zembutsu, M Yanada, A Hishida, Toyomasa Katagiri, T Tsuruo, I Sugiura, J Takeuchi, N Usui, T Naoe, Y Nakamura and R Ohno :
Prediction of risk of disease recurrence by genome-wide cDNA microarray analysis in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy,
International Journal of Oncology, Vol.31, No.2, 313-322, 2007.
(PubMed: 17611687,   Elsevier: Scopus)
78. M Fujikawa, Toyomasa Katagiri, A Tugores, Y Nakamura and F Ishikawa :
ESE-3, an Ets family transcription factor, is up-regulated in cellular senescence,
Cancer Science, Vol.98, No.9, 1468-1475, 2007.
(DOI: 10.1111/j.1349-7006.2007.00543.x,   PubMed: 17627613)
79. M Kanehira, Y Harada, R Takata, T Shuin, T Miki, T Fujioka, Y Nakamura and Toyomasa Katagiri :
Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis,
Oncogene, Vol.26, No.44, 6448-55, 2007.
(DOI: 10.1038/sj.onc.1210466,   PubMed: 17452976)
80. M Kanehira, Toyomasa Katagiri, A Shimo, R Takata, T Shuin, T Miki, T Fujioka and Y Nakamura :
Oncogenic role of MPHOSPH1, a cancer-testis antigen specific to human bladder cancer,
Cancer Research, Vol.67, No.7, 3276-85, 2007.
(DOI: 10.1158/0008-5472.CAN-06-3748,   PubMed: 17409436)
81. A Shimo, T Nishidate, T Ohta, M Fukuda, Y Nakamura and Toyomasa Katagiri :
Elevated expression of PRC1, protein regulator of cytokinesis 1, involved in the growth of breast cancer cells,
Cancer Science, Vol.98, No.2, 174-181, 2007.
(DOI: 10.1111/j.1349-7006.2006.00381.x,   PubMed: 17233835)
82. Ryo Takata, Toyomasa Katagiri, Mitsugu Kanehira, Taro Shuin, Tsuneharu Miki, Mikio Namiki, Kenjiro Kohri, Tatsuhiko Tsunoda, Tomoaki Fujioka and Yusuke Nakamura :
Validation study of the prediction system for clinical response of M-VAC neoadjuvant chemotherapy.,
Cancer Science, Vol.98, No.1, 113-117, 2007.
(DOI: 10.1111/j.1349-7006.2006.00366.x,   PubMed: 17116130)
83. ML Lin, JH Park, T Nishidate, Y Nakamura and Toyomasa Katagiri :
Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family.,
Breast Cancer Research, Vol.9, No.1, R17, 2007.
(DOI: 10.1186/bcr1650,   PubMed: 17280616)
84. E Hirota, L Yan, T Tsunoda, S Ashida, M Fujime, T Shuin, T Miki, Y Nakamura and Toyomasa Katagiri :
Genome-wide gene expression profiles of clear cell renal cell carcinoma; Identification of molecular targets for treatment of renal cell carcinoma,
International Journal of Oncology, Vol.29, No.4, 799-827, 2006.
(PubMed: 16964377,   Elsevier: Scopus)
85. JH Park, ML Lin, T Nishidate, Y Nakamura and Toyomasa Katagiri :
PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen having an oncogenic activity in breast cancer,
Cancer Research, Vol.66, No.18, 9186-95, 2006.
(DOI: 10.1158/0008-5472.CAN-06-1601,   PubMed: 16982762)
86. M Iiizumi, M Hosokawa, A Takehara, S Chung, T Nakamura, Toyomasa Katagiri, H Eguchi, H Ohigashi, O Ishikawa, Y Nakamura and H Nakagawa :
EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma, promotes cancer cell growth,
Cancer Science, Vol.97, No.11, 1211-1216, 2006.
(DOI: 10.1111/j.1349-7006.2006.00313.x,   PubMed: 16965393)
87. A Takehara, H Eguchi, H Ohigashi, O Ishikawa, T Kasugai, M Hosokawa, Toyomasa Katagiri, Y Nakamura and H Nakagawa :
Novel tumor marker REG4 detected in serum of patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4,
Cancer Science, Vol.97, No.11, 1191-1197, 2006.
(DOI: 10.1111/j.1349-7006.2006.00297.x,   PubMed: 16918991)
88. S Ashida, M Furihata, Toyomasa Katagiri, K Tamura, Y Anazawa, M Yoshioka, T Miki, T Fujioka, T Shuin, Y Nakamura and H Nakagawa :
Expression of novel molecules, MICAL2-PV (MICAL2 prostate cancer variants), increases with high Gleason score and prostate cancer progression,
Clinical Cancer Research, Vol.12, No.9, 2767-2773, 2006.
(DOI: 10.1158/1078-0432.CCR-05-1995,   PubMed: 16675569)
89. T Kikuchi, Y Daigo, N Ishikawa, Toyomasa Katagiri, T Tsunoda, S Yoshida and Y Nakamura :
Expression profiles of metastatic brain tumor from lung adenocarcinomas on cDNA microarray,
International Journal of Oncology, Vol.28, No.4, 799-805, 2006.
(PubMed: 16525627,   Elsevier: Scopus)
90. R Hamamoto, FP Silva, M Tsuge, T Nishidate, Toyomasa Katagiri, Y Nakamura and Y Furukawa :
Enhanced SMYD3 expression is essential for the growth of breast cancer cells,
Cancer Science, Vol.97, No.2, 113-118, 2006.
(DOI: 10.1111/j.1349-7006.2006.00146.x,   PubMed: 16441421)
91. JR Morris, L Pangon, C Boutell, Toyomasa Katagiri, NH Keep and E Solomon :
Genetic analysis of BRCA1 ubiquitin ligase activity and its relationship to breast cancer susceptibility,
Human Molecular Genetics, Vol.15, No.4, 599-606, 2006.
(DOI: 10.1093/hmg/ddi476,   PubMed: 16403807,   Elsevier: Scopus)
92. Seiji Tachiiri, Toyomasa Katagiri, Tatsuhiko Tsunoda, Natsuo Oya, Masahiro Hiraoka and Yusuke Nakamura :
Analysis of gene-expression profiles after gamma irradiation of normal human fibroblasts,
International Journal of Radiation Oncology*Biology*Physics, Vol.64, No.1, 272-279, 2006.
(DOI: 10.1016/j.ijrobp.2005.08.030,   PubMed: 16257130,   Elsevier: Scopus)
93. S Nagayama, C Fukukawa, Toyomasa Katagiri, T Okamoto, T Aoyama, N Oyaizu, M Imamura, J Toguchida and Y Nakamura :
Therapeutic potential of antibodies against FZD10, a cell-surface protein, for synovial sarcomas,
Oncogene, Vol.24, No.41, 6201-6212, 2005.
(DOI: 10.1038/sj.onc.1208780,   PubMed: 16007199)
94. A Togashi, Toyomasa Katagiri, S Ashida, T Fujioka, O Maruyama, Y Wakumoto, Y Sakamoto, M Fujime, Y Kawachi, T Shuin and Y Nakamura :
Hypoxia-inducible protein 2 (HIG2), a novel diagnostic marker for renal cell carcinoma (RCC) and potential target for molecular therapy,
Cancer Research, Vol.65, No.11, 4817-4826, 2005.
(DOI: 10.1158/0008-5472.CAN-05-0120,   PubMed: 15930302)
95. Y Anazawa, H Nakagawa, M Furihara, S Ashida, K Tamura, H Yoshioka, T Shuin, T Fujioka, Toyomasa Katagiri and Y Nakamura :
PCOTH, a novel gene overexpressed in prostate cancers, promotes prostate cancer cell growth through phosphorylation of oncoprotein TAF-Ibeta/SET.,
Cancer Research, Vol.65, No.11, 4578-4586, 2005.
(DOI: 10.1158/0008-5472.CAN-04-4564,   PubMed: 15930275)
96. K Obama, K Ura, M Li, Toyomasa Katagiri, T Tsunoda, A Nomura, S Satoh, Y Nakamura and Y Furukawa :
Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma,
Hepatology, Vol.41, No.6, 1339-48, 2005.
(DOI: 10.1002/hep.20718,   PubMed: 15880566)
97. K Taniuchi, H Nakagawa, M Hosokawa, T Nakamura, H Eguchi, H Ohigashi, O Ishikawa, Toyomasa Katagiri and Y Nakamura :
Overexpressed P-cadherin/CDH3 promotes motility of pancreatic cancer cells by interacting with p120ctn and activating rho-family GTPases,
Cancer Research, Vol.65, No.8, 3092-3099, 2005.
(DOI: 10.1158/0008.5472.CAN-04-3646,   PubMed: 15833838)
98. T Ishibe, T Nakayama, T Okamoto, T Aoyama, K Nishijo, KR Shibata, Y Shima, S Nagayama, Toyomasa Katagiri, Y Nakamura, T Nakamura and J. Toguchida :
Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy,
Clinical Cancer Research, Vol.11, No.7, 2702-12, 2005.
(DOI: 10.1158/1078-0432.CCR-04-2057,   PubMed: 15814652)
99. R Takata, Toyomasa Katagiri, M Kanehira, T Tsunoda, T Shuin, T Miki, M Namiki, K Kohri, Y Matsushita, T Fujioka and Y Nakamura :
Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling,
Clinical Cancer Research, Vol.11, No.7, 2625-36, 2005.
(DOI: 10.1158/1078-0432.CCR-04-1988,   PubMed: 15814643)
100. K Taniuchi, H Nakagawa, T Nakamura, H Eguchi, H Ohigashi, O Ishikawa, Toyomasa Katagiri and Y Nakamura :
Down-regulation of RAB6KIFL/KIF20A, a kinesin involved with membrane trafficking of discs large homologue 5, can attenuate growth of pancreatic cancer cell,
Cancer Research, Vol.65, No.1, 105-112, 2005.
(PubMed: 15665285)
101. K Okada, E Hirota, Y Mizutani, T Fujioka, T Shuin, T Miki, Y Nakamura and Toyomasa Katagiri :
Oncogenic role of NALP7 in testicular seminomas,
Cancer Science, Vol.95, No.12, 949-954, 2004.
(DOI: 10.1111/j.1349-7006.2004.tb03182.x,   PubMed: 15596043,   CiNii: 10014260493)
102. H Kamiyama, K Kurosaki, M Kurimoto, Toyomasa Katagiri, Y Nakamura, M Kurokawa, H Sato, S Endo and K Shiraki :
Herpes simplex virus-induced, death receptor-dependent apoptosis and regression of transplanted human cancers,
Cancer Science, Vol.95, No.12, 990-998, 2004.
(DOI: 10.1111/j.1349-7006.2004.tb03188.x,   PubMed: 15596049,   CiNii: 10014260689)
103. Tetsuya Nakatsura, Hiroyuki Komori, Tatsuko Kubo, Yoshihiro Yoshitake, Satoru Senju, Toyomasa Katagiri, Yoichi Furukawa, Michio Ogawa, Yusuke Nakamura and Yasuharu Nishimura :
Mouse homologue of a novel human oncofetal antigen, glypican-3, evokes T-cell-mediated tumor rejection without autoimmune reactions in mice,
Clinical Cancer Research, Vol.10, No.24, 8630-40, 2004.
(DOI: 10.1158/1078-0432.CCR-04-1177,   PubMed: 15623647)
104. Y Yoshitake, T Nakatsura, M Monji, S Senju, H Matsuyoshi, H Tsukamoto, S Hosaka, H Komori, D Fukuma, Y Ikuta, Toyomasa Katagiri, Y Furukawa, H Ito, M Shinohara, Y Nakamura and Y Nishimura :
Proliferation potential-related protein, an ideal esophageal cancer antigen for immunotherapy, identified using complementary DNA microarray analysis,
Clinical Cancer Research, Vol.10, No.19, 6437-48, 2004.
(DOI: 10.1158/1078-0432.CCR-04-0841,   PubMed: 15475430,   CiNii: 30018692239)
105. T Nishidate, Toyomasa Katagiri, ML Lin, Y Mano, Y Miki, F Kasumi, M Yoshimoto, T Tsunoda, K Hirata and Y Nakamura :
Genome-wide gene-expression profiles of breast-cancer cells purified with laser microbeam microdissection: identification of genes associated with progression and metastasis,
International Journal of Oncology, Vol.25, No.4, 797-819, 2004.
(PubMed: 15375528)
106. Y Harima, A Togashi, K Horikoshi, M Imamura, M Sougawa, S Sawada, T Tsunoda, Y Nakamura and Toyomasa Katagiri :
Prediction of outcome of advanced cervical cancer to thermoradiotherapy according to expression profiles of 35 genes selected by cDNA microarray analysis,
International Journal of Radiation Oncology*Biology*Physics, Vol.60, No.1, 237-248, 2004.
(DOI: 10.1016/j.ijrobp.2004.02.047,   PubMed: 15337562)
107. Shingo Ashida, Hidewaki Nakagawa, Toyomasa Katagiri, Mutsuo Furihata, Megumi Iiizumi, Yoshio Anazawa, Tatsuhiko Tsunoda, Ryo Takata, Kotaro Kasahara, Tsuneharu Miki, Tomoaki Fujioka, Taro Shuin and Yusuke Nakamura :
Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: genome-wide gene-expression profiles of prostate cancers and PINs,
Cancer Research, Vol.64, No.17, 5963-5972, 2004.
(DOI: 10.1158/0008-5472.CAN-04-0020,   PubMed: 15342375)
108. S Nagayama, M Iiizumi, Toyomasa Katagiri, J Toguchida and Y Nakamura :
Identification of PDZK4, a novel human gene with PDZ domains, that is up-regulated in synovial sarcomas,
Oncogene, Vol.23, No.32, 5551-7, 2004.
(DOI: 10.1038/sj.onc.1207710,   PubMed: 15077175)
109. T Nakamura, Y Furukawa, H Nakagawa, T Tsunoda, H Ohigashi, K Murata, O Ishikawa, K Ohgaki, N Kashimura, M Miyamoto, S Hirano, S Kondo, H Katoh, Y Nakamura and Toyomasa Katagiri :
Genome-wide cDNA microarray analysis of gene-expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection,
Oncogene, Vol.23, No.13, 2385-400, 2004.
(DOI: 10.1038/sj.onc.1207392,   PubMed: 14767473,   CiNii: 30013808552)
110. K Ochi, Y Daigo, Toyomasa Katagiri, S Nagayama, T Tsunoda, A Myoui, N Naka, N Araki, I Kudawara, M Ieguchi, Y Toyama, J Toguchida, H Yoshikawa and Y Nakamura :
Prediction of response to neoadjuvant chemotherapy for osteosarcoma by gene-expression profiles,
International Journal of Oncology, Vol.24, No.3, 647-655, 2004.
(PubMed: 14767549)
111. M Li, YM Lin, S Hasegawa, T Shimokawa, K Murata, M Kameyama, O Ishikawa, Toyomasa Katagiri, T Tsunoda, Y Nakamura and Y Furukawa :
Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray,
International Journal of Oncology, Vol.24, No.2, 305-312, 2004.
(PubMed: 14719106)
112. K Okada, Toyomasa Katagiri, K Okada, Y Mizutani, Y Suzuki, M Kamada, T Fujioka, T Shuin, T Miki and Y Nakamura :
Analysis of gene-expression profiles in testicular seminomas using a genome-wide cDNA microarray,
International Journal of Oncology, Vol.23, No.6, 1615-1635, 2003.
(PubMed: 14612934)
113. C Suzuki, Y Daigo, T Kikuchi, Toyomasa Katagiri and Y Nakamura :
Identification of COX17 as a therapeutic target for non-small cell lung cancer,
Cancer Research, Vol.63, No.21, 7038-7041, 2003.
(PubMed: 14612491)
114. Y Kaneta, Y Kagami, T Tsunoda, R Ohno, Y Nakamura and Toyomasa Katagiri :
Genome-wide analysis of gene-expression profiles in chronic myeloid leukemia cells using a cDNA microarray,
International Journal of Oncology, Vol.23, No.3, 681-691, 2003.
(PubMed: 12888904)
115. H Zembutsu, Y Ohnishi, Y Daigo, Toyomasa Katagiri, T Kikuchi, S Kakiuchi, C Nishime, K Hirata and Y Nakamura :
Gene-expression profiles of human tumor xenografts in nude mice treated orally with the EGFR tyrosine kinase inhibitor ZD1839,
International Journal of Oncology, Vol.23, No.1, 29-39, 2003.
(PubMed: 12792773)
116. T Nakatsura, Y Yoshitake, S Senju, M Monji, H Komori, Y Motomura, S Hosaka, T Beppu, T Ishiko, H Kamohara, H Ashihara, Toyomasa Katagiri, Y Furukawa, S Fujiyama, M Ogawa, Y Nakamura and Y Nishimura :
Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker,
Biochemical and Biophysical Research Communications, Vol.306, No.1, 16-25, 2003.
(DOI: 10.1016/S0006-291X(03)00908-2,   PubMed: 12788060,   CiNii: 80016037103)
117. Takefumi Kikuchi, Yataro Daigo, Toyomasa Katagiri, Tatsuhiko Tsunoda, Koichi Okada, Soji Kakiuchi, Hitoshi Zembutsu, Yoichi Furukawa, Masafumi Kawamura, Koichi Kobayashi, Kohzoh Imai and Yusuke Nakamura :
Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs,
Oncogene, Vol.22, No.14, 2192-205, 2003.
(DOI: 10.1038/sj.onc.1206288,   PubMed: 12687021,   CiNii: 30013807418)
118. T Arimoto, Toyomasa Katagiri, K Oda, T Tsunoda, T Yasugi, Y Osuga, H Yoshikawa, O Nishii, T Yano, Y Taketani and Y Nakamura :
Genome-wide cDNA microarray analysis of gene-expression profiles involved in ovarian endometriosis,
International Journal of Oncology, Vol.22, No.3, 551-560, 2003.
(PubMed: 12579308)
119. K Ochi, Y Daigo, Toyomasa Katagiri, A Saito-Hisaminato, T Tsunoda, Y Toyama, H Matsumoto and Y Nakamura :
Expression profiles of two types of human knee-joint cartilage,
Journal of Human Genetics, Vol.48, No.4, 177-182, 2003.
(DOI: 10.1007/s10038-003-0004-8,   PubMed: 12730720,   CiNii: 10011594406)
120. Satoko Abe, Toyomasa Katagiri, Akihiko Saito-Hisaminato, Shin-ichi Usami, Yasuhiro Inoue, Tatsuhiko Tsunoda and Yusuke Nakamura :
Identification of CRYM as a candidate responsible for nonsyndromic deafness, through cDNA microarray analysis of human cochlear and vestibular tissues.,
American Journal of Human Genetics, Vol.72, No.1, 73-82, 2003.
(DOI: 10.1086/345398,   PubMed: 12471561)
121. S Hasegawa, Y Furukawa, M Li, S Satoh, T Kato, T Watanabe, Toyomasa Katagiri, T Tsunoda, Y Yamaoka and Y. Nakamura :
Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes,
Cancer Research, Vol.62, No.23, 7012-7017, 2002.
(PubMed: 12460921)
122. S Nagamaya, Toyomasa Katagiri, T Tsunoda, T Hosaka, Y Nakashima, N Araki, K Kusuzaki, T Nakayama, T Tsuboyama, T Nakamura, M Imamura, Y Nakamura and J. Toguchida :
Genome-wide analysis of gene expression in synovial sarcomas using a cDNA microarray,
Cancer Research, Vol.62, No.20, 5859-5866, 2002.
(PubMed: 12384549)
123. M Brown, H Nicolai, K Howe, Toyomasa Katagiri, E Lalani, K Simpson, N Manning, A Deans, P Chen, KK Khanna, MR Wati, B Griffiths, C Xu, G Stamp and E. Solomon :
Expression of a truncated Brca1 protein delays lactational mammary development in transgenic mice,
Transgenic Research, Vol.11, No.5, 467-478, 2002.
(DOI: 10.1023/A:1020348025139,   PubMed: 12437078)
124. J Okutsu, T Tsunoda, Y Kaneta, Toyomasa Katagiri, O Kitahara, H Zembutsu, R Yanagawa, S Miyawaki, K Kuriyama, N Kubota, Y Kimura, K Kubo, F Yagasaki, T Higa, H Taguchi, T Tobita, H Akiyama, A Takeshita, Y Wang, T Motoji, R Ohno and Y Nakamura :
Prediction of chemosensitivity for patients with acute myeloid leukemia, according to expression levels of 28 genes selected by genome-wide complementary DNA microarray analysis,
Molecular Cancer Therapeutics, Vol.1, No.12, 1035-1042, 2002.
(PubMed: 12481426)
125. Y Kaneta, Y Kagami, Toyomasa Katagiri, T Tsunoda, I Jin-nai, H Taguchi, H Hirai, K Ohnishi, T Ueda, N Emi, A Tomida, T Tsuruo, Y Nakamura and R. Ohno :
Prediction of sensitivity to STI571 among chronic myeroid leukemia patients by genome-wide cDNA microarray analysis,
Japanese Journal of Cancer Research, Vol.93, No.8, 849-856, 2002.
(PubMed: 12716460)
126. K Miura, ED Bowman, R Simon, AC Peng, AI Robles, RT Jones, Toyomasa Katagiri, P He, H Mizukami, L Charboneau, T Kikuchi, LA Liotta, Y Nakamura and CC. Harris :
Laser capture microdissection and microarray expression analysis of lung adenocarcinoma reveals tobacco smoking and prognosis-related molecular profiles.,
Cancer Research, Vol.62, No.11, 3244-3250, 2002.
(PubMed: 12036940)
127. Osamu Kitahara, Toyomasa Katagiri, Tatsuhiko Tsunoda, Yoko Harima and Yusuke Nakamura :
Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis.,
Neoplasia, Vol.4, No.4, 295-303, 2002.
(DOI: 10.1038/sj.neo.7900251,   PubMed: 12082545)
128. A Saito-Hisaminato, Toyomasa Katagiri, S Kakiuchi, T Nakamura, T Tsunoda and Y Nakamura :
Genome-wide profiling of gene expression in 29 normal human tissues with a cDNA microarray.,
DNA Research, Vol.9, No.2, 35-45, 2002.
(DOI: 10.1093/dnares/9.2.35,   PubMed: 12056413)
129. Shingo Dan, Tatsuhiko Tsunoda, Osamu Kitahara, Rempei Yanagawa, Hitoshi Zembutsu, Toyomasa Katagiri, Kanami Yamazaki, Yusuke Nakamura and Takao Yamori :
An Integrated Database of Chemosensitivity to 55 Anticancer Drugs and Gene Expression Profiles of 39 Human Cancer Cell Lines,
Cancer Research, Vol.62, No.4, 1139-47, 2002.
(PubMed: 11861395,   Elsevier: Scopus)
130. H Zembutsu, Y Ohnishi, T Tsunoda, Y Furukawa, Toyomasa Katagiri, Y Ueyama, N Tamaoki, T Nomura, O Kitahara, R Yanagawa, K Hirata and Y. Nakamura :
Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human cancer xenografts to anticancer drugs.,
Cancer Research, Vol.62, No.2, 518-527, 2002.
(PubMed: 11809704)
131. K Maeda, S Matsuhashi, K Tabuchi, T Watanabe, Toyomasa Katagiri, M Oyasu, N Saito and S. Kuroda :
Brain specific human genes, NELL1 and NELL2, are predominantly expressed in neuroblastoma and other embryonal neuroepithelial tumors,
Neurologia Medico-Chirurgica, Vol.41, No.12, 582-589, 2001.
(DOI: 10.2176/nmc.41.582,   PubMed: 11803583)
132. M Futamura, H Arakawa, K Matsuda, Toyomasa Katagiri, S Saji, Y Miki and Y. Nakamura :
Potential role of BRCA2 in a mitotic checkpoint after phosphorylation by hBUBR1,
Cancer Research, Vol.60, No.6, 1531-1535, 2000.
(PubMed: 10749118,   Elsevier: Scopus)
133. M Kato, K Yano, F Matsuo, H Saito, Toyomasa Katagiri, H Kurumizaka, M Yoshimoto, F Kasumi, F Akiyama, G Sakamoto, H Nagawa, Y Nakamura and Y Miki :
Identification of Rad51 alteration in patients with bilateral breast cancer,
Journal of Human Genetics, Vol.45, No.3, 133-137, 2000.
(DOI: 10.1007/s100380050199,   PubMed: 10807537)
134. M Emi, M Yoshimoto, T Sato, S Matsumoto, Y Utada, I Ito, K Minobe, T Iwase, Toyomasa Katagiri, K Bando, F Akiyama, Y Harada, K Fukino, G Sakamoto, M Matsushima, A Iida, T Tada, H Saito, Y Miki, F Kasumi and Y Nakamura :
Allelic loss at 1p34, 13q12, 17p13.3, and 17q21.1 correlates with poor postoperative prognosis in breast cancer.,
Genes, Chromosomes & Cancer, Vol.26, No.2, 134-141, 1999.
(PubMed: 10469451)
135. Toyomasa Katagiri, M Futamura and Y. Nakamura :
A Gln/Arg polymorphism at codon 349 of the hBUBR1 gene.,
Journal of Human Genetics, Vol.44, No.2, 131-2, 1999.
(DOI: 10.1007/s100380050126,   PubMed: 10083741,   CiNii: 10011568274,   Elsevier: Scopus)
136. M Emi, M Matsushima, Toyomasa Katagiri, T Yokota, T Nakata, F Kasumi, Y Miki, MH Skolnick and Y. Nakamura :
Multiplex mutation screening of the BRCA1 gene in 1000 Japanese breast cancers: 2-3% of Japanese breast cancer is attributable to BRCA1 mutations.,
Japanese Journal of Cancer Research, Vol.89, No.1, 12-16, 1998.
(PubMed: 9510469)
137. Toyomasa Katagiri, F Kasumi, M Yoshimoto, K Asaishi, R Abe, A Tsuchiya, M Sugano, T Nomizu, S Takai, M Yoneda, K Nanba, M Makita, H Okazaki, K Hirata, M Okazaki, Y Furutsuma, Y Morishita, Y Iino, T Karino, T Fukutomi, H Ayabe, S Hara, T Kajiwara, S Houga, T Shimizu, M Toda, Y Yamasaki, T Uchida, K Kunitomo, H Sonoo, J Kurebayashi, K Shimotuma, Y Nakamura and Y. Miki :
High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families.,
Journal of Human Genetics, Vol.43, No.1, 42-48, 1998.
(DOI: 10.1007/s100380050035,   PubMed: 9609997)
138. Toyomasa Katagiri, H Saito, A Shinohara, H Ogawa, N Kamada, Y Nakamura and Y. Miki :
Multiple possible sites of BRCA2 interacting with DNA repair protein Rad51.,
Genes Chromosomes Cancer., Vol.21, 217-22, 1998.
139. O Maruyama, H Nishimori, Toyomasa Katagiri, Y Miki, A Ueno and Y. Nakamura :
Cloning of TCFL5 encoding a novel human basic helix-loop-helix motif protein that is specifically expressed in primary spermatocytes at the pachytene stage,
Cytogenetics and Cell Genetics, Vol.82, No.1-2, 41-5, 1998.
(DOI: 10.1159/000015061,   PubMed: 9763657)
140. Y Miki, Toyomasa Katagiri and Y. Nakamura :
Infrequent mutation of the H-Cadherin gene on chromosome 16q24 in human breast cancers.,
Japanese Journal of Cancer Research, Vol.88, No.8, 701-704, 1997.
(PubMed: 9330599)
141. S Takeda, T Fujiwara, F Shimizu, A Kawai, K Shinomiya, S Okuno, K Ozaki, Toyomasa Katagiri, Y Shimada, M Nagata, T Watanabe, A Takaichi, Y Kuga, M Suzuki, H Hishigaki, E Takahashi, S Shin, Y Nakamura and Y Hirai :
Isolation and mapping of karyopherin alpha 3 (KPNA3), a human gene that is highly homologous to genes encoding Xenopus importin, yeast SRP1 and human RCH1.,
Cytogenetics and Cell Genetics, Vol.76, No.1-2, 87-93, 1997.
(DOI: 10.1159/000134521,   PubMed: 9154134)
142. F Shimizu, Toyomasa Katagiri, M Suzuki, K T Watanabe, S Okuno, Y Kuga, M Nagata, T Fujiwara, Y Nakamura and E Takahashi :
Cloning and chromosome assignment to 1q32 of a human cDNA (RAB7L1) encoding a small GTP-binding protein, a member of the RAS superfamily.,
Cytogenetics and Cell Genetics, Vol.77, No.3-4, 261-263, 1997.
(DOI: 10.1159/000134591,   PubMed: 9284931)
143. Toyomasa Katagiri, Y Nakamura and Y Miki :
Mutations in the BRCA2 gene in hepatocellular carcinomas.,
Cancer Research, Vol.56, No.20, 4575-4577, 1996.
(PubMed: 8840963)
144. Y Miki, Toyomasa Katagiri, F Kasumi, T Yoshimoto and Y. Nakamura :
Mutation analysis in the BRCA2 gene in primary breast cancers,
Nature Genetics, Vol.13, No.2, 245-247, 1996.
(DOI: 10.1038/ng0696-245,   PubMed: 8640237)
145. Toyomasa Katagiri, M Emi, I Ito, K Kobayashi, M Yoshimoto, T Iwase, F Kasumi, Y Miki, H M Skolnick and Y Nakamura :
Mutations in the BRCA1 gene in Japanese breast cancer patients.,
Human Mutation, Vol.7, No.4, 334-339, 1996.
(DOI: 10.1002/(SICI)1098-1004(1996)7:4<334::AID-HUMU7>3.0.CO;2-8,   PubMed: 8723683)
146. Toyomasa Katagiri, K Ozaki, T Fujiwara, F Shimizu, A Kawai, S Okuno, M Suzuki, Y Nakamura, E Takahashi and Y. Hirai :
Cloning, expression, and chromosome mapping of adducin-(alpha) like 1 (ADDL1), a human cDNA highly homologous to human erythrocyte adducin,
Cytogenet Cell Genet., Vol.74, 90-5, 1996.
147. TK* Watanabe, Toyomasa Katagiri, M Suzuki, F Shimizu, T Fujiwara, N Kanemoto, Y Nakamura, Y Hirai, H Maekawa and E. Takahashi :
Cloning and characterization of two novel human cDNAs (NELL1 and NELL2) encoding proteins with six EGF-like repeats,
Genomics, Vol.38, 273-6, 1996.
148. I Ito, M Yoshimoto, T Iwase, S Watanabe, Toyomasa Katagiri, Y Harada, F Kasumi, S Yasuda, T Mitomi and M Emi :
Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer.,
British Journal of Cancer, Vol.71, No.3, 438-441, 1995.
(PubMed: 7880720)
149. Toyomasa Katagiri, Y Harada, M Emi and Y Nakamura :
Human metalloprotease/disintegrin-like (MDC) gene: exon-intron organization and alternative splicing.,
Cytogenetics and Cell Genetics, Vol.68, No.1-2, 39-44, 1995.
(DOI: 10.1159/000133884,   PubMed: 7956356)
150. M Ichii, Toyomasa Katagiri, H Hasegawa, O Yatou, DW Kirk and JL. Wray :
Biochemical characterization of rice (Oryza sativa L.) mutants defective or low in nitrate reduction,
Tech Bull Fac Agric Kagawa University, Vol.47, 1-6, 1995.
151. M Isomura, A Tanigami, H Saito, Y Harada, Toyomasa Katagiri, J Inazawa, H D Ledbetter and Y Nakamura :
Detailed analysis of loss of heterozygosity on chromosome band 17p13 in breast carcinoma on the basis of a high-resolution physical map with 29 markers.,
Genes, Chromosomes & Cancer, Vol.9, No.3, 173-179, 1994.
(PubMed: 7515659)
152. M Isomura, A Tanigami, H Saito, Y Harada, Toyomasa Katagiri, J Inazawa, DH Ledbetter and Y. Nakamura :
Detailed analysis of heterozygosity on chromosome band 17p13 in breast carcinoma on the basis of a high-resolution physical map with 29 markers,
Genes Chromosomes Cancer, Vol.9, 173-9, 1994.
153. Y; Harada, Toyomasa Katagiri, I Ito, F Akiyama, G Sakamoto, F Kasumi, Y Nakamura and M. Emi :
Genetic studies of 457 breast cancers. Clinicopathologic parameters compared with genetic alterations.,
Cancer., Vol.74, 2281-6, 1994.
154. M Emi, Toyomasa Katagiri, Y Harada, H Saito, J Inazawa, I Ito, F Kasumi and Y. Nakamura :
A novel metalloprotease/ disintegrin-like gene at 17q21.3 is somatically rearranged in two primary breast cancers,
Nature Genetics, Vol.5, No.2, 151-157, 1993.
(DOI: 10.1038/ng1093-151,   PubMed: 8252040)
155. M Ichii, Toyomasa Katagiri and H Hasegawa :
Mutants with low nitrate reductase activity selected from seedlings expressing nitrogen deficiency symptoms in rice (Oryza sativa L.),
Jpn J Breed., Vol.43, 123-7, 1993.
156. H Hasegawa, Toyomasa Katagiri, S Ida, O Yatou and M. Ichii :
Characterization of a rice (Oryza sativa L.) mutant deficient in the heme domain of nitrate reductase,
Theor Appl Genet., Vol.84, 6-9, 1992.
157. H Hasegawa, O Yatou, Toyomasa Katagiri and M. Ichii :
Screening for nitrate reductase deficient mutants in rice (Oryza sativa L.),
Jpn J Breed., Vol.41, 95-101, 1991.

Academic Paper (Unrefereed Paper):

1. Keitaroh Anyohji, Keisuke Aihara, Tetsuro Yoshimaru, Akira Shigenaga, Toyomasa Katagiri and Akira Otaka :
Development of anti-cancer peptide based on prohibitin 2,
Peptide Science 2018, 46, 2019.

Review, Commentary:

1. Tetsuro Yoshimaru and Toyomasa Katagiri :
Targeting BIG3-PHB2 interaction potentiates an effective therapy for hormone-dependent breast cancer,
The Medical Frontline, Vol.74, No.5, 115-121, 2019.
2. Tetsuro Yoshimaru, Yosuke Matsushita and Toyomasa Katagiri :
Elucidating Molecular-mechanism of Triple-negative Breast Cancer Through Comprehensive Genome Analysis,
Japanese Journal of Breast Cancer, Vol.31, No.5, 377-385, Oct. 2016.
3. Tetsuro Yoshimaru, Yosuke Matsushita and Toyomasa Katagiri :
Elucidating Molecular-mechanism of Triple-negative Breast Cancer Through Comprehensive Genome Analysis,
Japanese Journal of Breast Cancer, Vol.31, No.5, 377-385, Oct. 2016.
4. Toyomasa Katagiri :
トリプルネガティブ乳がんの研究に関するコラム,
徳島新聞, Dec. 2012.
5. Toyomasa Katagiri :
癌治療薬に関するコラム,
徳島新聞, Apr. 2012.
6. Toyomasa Katagiri :
[Cancer diagnosis].,
Nihon Rinsho. Japanese Journal of Clinical Medicine, Vol.68 Suppl 8, 134-138, Aug. 2010.
(PubMed: 20979271)
7. Toyomasa Katagiri :
ミトコンドリアが小胞体と並んでいるわけは?,
Experimental Medicine, Vol.27, No.4, 528-529, Mar. 2009.
8. Toyomasa Katagiri, 高田 亮, 藤岡 知昭 and 中村 祐輔 :
網羅的発現情報解析を利用した癌の新規治療薬開発への戦略,
がん分子標的治療研究, 279-285, 2009.
9. Toyomasa Katagiri and 中村 祐輔 :
遺伝子発現解析に基づいた分子標的治療の開発,
がんの分子標的治療, 67-72, Sep. 2008.
10. Toyomasa Katagiri and 中村 祐輔 :
オーダーメイド医療,
遺伝子医学MOOK, Vol.10, 296-303, Jun. 2008.
11. Toyomasa Katagiri :
腎細胞癌における新規診断および治療のための標的分子の同定,
がん分子標的治療, 67-72, 2008.
12. Toyomasa Katagiri and 中村 祐輔 :
網羅的発現情報解析を利用した癌の新規治療薬開発への戦略,
バイオテクノロジー ジャーナル, Vol.7, No.3, 296-300, May 2007.
(CiNii: 40015466736)
13. Toyomasa Katagiri and 中村 祐輔 :
腎細胞癌における新規診断および治療のための標的分子の同定,
Cancer Frontier, Vol.9, No.1, 127-36, 2007.
(CiNii: 40015656049)
14. Toyomasa Katagiri :
概論:ゲノム研究に基づく癌の個別化医療,
実験医学増刊, Vol.25, 2608-14, 2007.
15. Toyomasa Katagiri and 中村 祐輔 :
遺伝子発現解析に基づいた抗がん剤感受性予測法の開発,
Radiation Biology Research Communications, Vol.41, 245-54, 2006.
16. C Fukukawa, Yusuke Nakamura and Toyomasa Katagiri :
Molecular target therapy for synovial sarcoma.,
Future Oncology, Vol.1, No.6, 805-812, Dec. 2005.
(DOI: 10.2217/14796694.1.6.805,   PubMed: 16556060)
17. Toyomasa Katagiri and 中村 祐輔 :
グリベックに対する薬剤感受性診断,
Journal of Medical Technology, Vol.49, 516-21, 2005.
18. Toyomasa Katagiri and 中村 祐輔 :
慢性骨髄性白血病におけるグリベック感受性予測診断法の開発,
臨床化学, Vol.34, 102-7, 2005.
19. Toyomasa Katagiri and 中村 祐輔 :
発現情報解析に基づく抗癌剤治療の最適化戦略,
バイオベンチャー, Vol.3, 13-21, 2003.
20. Toyomasa Katagiri and 三木 義男 :
ノックアウトマウス・データブック,BRCA1, BRCA2,
Molecular Medicine, No.34, 57-8, 1997.
21. Toyomasa Katagiri and 三木 義男 :
乳癌におけるBRCA1, BRCA2遺伝子の役割,
Molecular Medicine, Vol.34, 706-12, 1997.
22. Toyomasa Katagiri and 三木 義男 :
遺伝性癌 癌抑制遺伝子,癌遺伝子,DNA修復遺伝子の役割,
Experimental Medicine, Vol.15, 873-8, 1997.
23. Toyomasa Katagiri and 三木 義男 :
家族性乳癌—原因遺伝子探求の現状,
Experimental Medicine, Vol.14, 674-7, 1996.
24. Toyomasa Katagiri :
疾患遺伝子解明と最前線,大動脈弁上部狭窄症,
実験医学増刊, Vol.12, 218-9, 1994.

Proceeding of International Conference:

1. Toyomasa Katagiri :
Targeting BIG3-PHB2 interaction to overcome endocrine-resistant breast cancer,
Satellite Meeting of International Society of Precision Cancer Medicine in Korea, Yeosu, Nov. 2019.
2. Yosuke Matsushita, Masato Komatsu, Kazuma Kiyotani, Tetsuro Yoshimaru, Suzuki Hiromu, Miyoshi Yasuo, Sasa Mitsunori and Toyomasa Katagiri :
Frequent downregulation of SALL3 by genetic and epigenetic alterations is involved in progression and chemoresistance of triple negative breast cancers,
American Association for Cancer Research ANNUAL MEETING 2019, Atlanta, Apr. 2019.
3. Tetsuro Yoshimaru, Yosuke Matsushita, Sasa Mitsunori, Miyoshi Yasuo and Toyomasa Katagiri :
PHB2 inactivation by AKAP-BIG3 is required for progression of HER2-overexpressing breast cancer,
American Association for Cancer Research ANNUAL MEETING 2019, Atlanta, Apr. 2019.
4. Toyomasa Katagiri :
Targeting RHBDL2-SLC1A5 axis to overcome chemoresistance and progression intriple negative breast cancer,
International Society of Precision Cancer Medicine (ISPCM) Annual Meeting 2019, Seoul, Mar. 2019.
5. Keitaroh Anyohji, Keisuke Aihara, Tetsuro Yoshimaru, Akira Shigenaga, Toyomasa Katagiri and Akira Otaka :
Development of anti-cancer peptide based on prohibitin 2,
10th International Peptide Symposium, Kyoto, Dec. 2018.
6. Toyomasa Katagiri :
Novel therapeutic strategy for breast cancer utilizing activation of tumor suppressor PHB2,
The 2nd International Symposium on Radiation Therapeutics and Biology The 34th Radiation Biology Center Internationl Symposium, Kyoto, Nov. 2018.
7. Toyomasa Katagiri :
Comprehensive molecular features of triple negative breast cancers,
The 13th International Symposium of the Institute Network for Biomedical Sciences joint with the 3rd Symposium of the Inter-University Research Network for Trans-Omics Medicine and the 28th Hot Spring Harbor Symposium, Fukuoka, Oct. 2018.
8. Yosuke Matsushita, Masato Komatsu, Kazuma Kiyotani, Tetsuro Yoshimaru, Suzuki Hiromu, Miyoshi Yasuo, Sasa Mitsunori and Toyomasa Katagiri :
Frequent downregulation of SALL3 by recurrent genetic and epigenetic alterations is involved in triple-negative breast cancers,
American Association for Cancer Research ANNUAL MEETING 2018, Vol.78, No.13, Chicago, Apr. 2018.
(DOI: 10.1158/1538-7445.AM2018-5315)
9. Tetsuro Yoshimaru, Yosuke Matsushita, Sasa Mitsunori, Miyoshi Yasuo and Toyomasa Katagiri :
Overcoming trastuzumab resistance in HER2-overexpressing breast cancer by utilizing PHB2, a tumor suppressor of multiple resistance pathways,
American Association for Cancer Research ANNUAL MEETING 2018, Chicago, Apr. 2018.
10. Toyomasa Katagiri, Kei Daizumoto, Tetsuro Yoshimaru, Yosuke Matsushita, Tomoya Fukawa, Ono Masaya and Hiro-omi Kanayama :
DDX31 cooperates with mutant p53 and EGFR to promote the multistep progression of invasive bladder cancer,
American Association For Cancer Research ANNUAL MEETING 2018, Chicago, Apr. 2018.
11. Toyomasa Katagiri :
Stapled BIG3 helical peptide ERAP potentiates anti-tumor activity for breast cancer therapeutics,
International Society of Precision Cancer Medicine Annual Meeting 2018, Busan, Mar. 2018.
12. Akira Otaka, Keisuke Aihara, Tetsuro Yoshimaru, Akira Shigenaga and Toyomasa Katagiri :
Development of long-lasting stapled peptides targeting BIG3-PHB2 interaction in breast cancer cells,
The 6th Pharmaceutical Sciences World Congress 2017, Stockholm, May 2017.
13. Toyomasa Katagiri :
Development of chemically modified peptide inhibitor ERAP targeting BIG3-PHB2 complex on hormone-resistant breast tumor,
American Association For Cancer Research ANNUAL MEETING 2017, Washington, D.C., Apr. 2017.
14. Tetsuro Yoshimaru and Toyomasa Katagiri :
Development of chemically modified peptide inhibitor ERAP targeting BIG3-PHB2 complex on hormone-resistant breast cancer,
2nd International Symposium of Molecular Medicine in Tokushima University, Tokushima, Nov. 2016.
15. Tetsuro Yoshimaru, Ono Masaya, Mizuguchi Kenji, Miyoshi Yasuo, Mitsunori Sasa and Toyomasa Katagiri :
A novel A-kinase anchoring protein BIG3, coordinates estrogen signalling in breast cancer cells,
The 12th International Conference on Protein Phosphatase, Oct. 2016.
16. Toyomasa Katagiri :
Novel targeting therapeutic strategy for treatment of endocrine resistant breast cancer,
Tne 34th Sapporo International Cancer Symposlum, Sapporo, Jun. 2015.
17. Toyomasa Katagiri :
Xanthohumol suppresses estrogen-signaling in endocrine resistant breast cancer through the specific inhibition of BIG3-PHB2 interactions,
American Association for Cancer Research (AACR) Annual Meeting 2015, Pennsylvania, Apr. 2015.
18. Toyomasa Katagiri :
Targeting BIG3-PHB2 interaction to overcome endocrine resistance in breast cancer cells,
2015 SNUCRI & SNUCH CANCER SYMPOSIUM, Hwasun, Korea, Apr. 2015.
19. Toyomasa Katagiri :
A novel AKAP protein, BIG3 coodinates estrogen signaling pathways in breast cancer cells.,
11th International Conference on Protein Phosphatase, Sendai, Nov. 2014.
20. Toyomasa Katagiri, Tetsuro Yoshimaru, Masato Komatsu and Taisuke Matsuo :
BIG3-PHB2 Interaction is a key therapeutic target in Iuminal-type of breast cancer.,
Amerian Association for Cancer Research (AACR) Annal Meeting 2014, San Diego, Apr. 2014.
21. Toyomasa Katagiri :
Overcoming Endocrine Resistance in Breast Cancer by Reactivation of Tumor Suppressor Protein,
2013 SNUCRI & SNUCH CANCER SYMPOSIUM, JEJU, May 2013.
22. Toyomasa Katagiri, Tomoya Fukawa, Taisuke Matsuo and Hiro-omi Kanayama :
DDX31 regulates p53 tumor suppressive activity in renal cell carcinomas,
Amerian Association for Cancer Research (AACR) Annal Meeting 2013, Washington, D.C., Apr. 2013.
23. Toyomasa Katagiri :
Regulation of estrogen-signaling in ER-positive breast cancer by tumor suppressor REA via ERAP1,
15th International Congress on Hormonal Steroids and Hormones & Cancer, Kanazawa, Nov. 2012.
24. Taisuke Matsuo, Ono Masaya, Tetsuro Yoshimaru, Miyoshi Yasuo, Sasa Mitsunori, Nakamura Yusuke and Toyomasa Katagiri :
Functional roles of a novel glycosyltrasnferase BCGT1 in breast cancer cells,
70th Annual Meeting of the Japanese Cancer Association, Oct. 2011.
25. Toyomasa Katagiri :
Novel targeting therapeutic strategy for treatment of estrogen-dependent breast cancer,
70th Annual Meeting of the Japanese Cancer Association, Oct. 2011.
26. Furu Moritoshi, Kajita Yoichiro, Nagayama Satoshi, Toyomasa Katagiri, Nakamura Yusuke and Toguchida Junya :
Identifiication of AFAP1L1 as a prognostic marker for spindle cell sarcomas,
70th Annual Meeting of the Japanese Cancer Association, Oct. 2011.
27. Elgazzar Seham, Zembutsu Hitoshi, Takahashi Atsushi, Nakashima Mitsuko, Kubo Michiaki, Toyomasa Katagiri, Miki Yoshio, Kamatani Naoyuki and Nakamura Yusuke :
A genome-wide association study identifies a locus associated with breast cancer in Japanese.,
Oct. 2011.
28. Yanai Ayako, Ito Takashi, Hirota Seiichi, Toyomasa Katagiri, Sasa Mitsunori, Tomita Naohiro and Miyoshi Yasuo :
Estrogen receptors may be down-regulated in pre-,and rare in postmemopausal breast cancers with low proliferation,
70th Annual Meeting of the Japanese Cancer Association, Oct. 2011.
29. Tomoya Fukawa, Ono Masaya, Hisanori Uehara, Taisuke Matsuo, Nakamura Yusuke, Hiro-omi Kanayama and Toyomasa Katagiri :
Identification and characterization of RCCDH as a novel molecular target for clear renal cell carcinoma.,
70th Annual Meeting of the Japanese Cancer Association, Oct. 2011.
30. Tetsuro Yoshimaru, Komatsu Masato, Taisuke Matsuo, Miyoshi Yasuo, Sasa Mitsunori, Nakamura Yusuke and Toyomasa Katagiri :
Novel modeling of ER signaling regulation in E2-dependent breast cancer - New therapeutic target for ERAP1-REA complex,
70th Annual Meeting of the Japanese Cancer Association, Oct. 2011.
31. 長山 聡, 高橋 亮, 井元 清哉, 布留 守敏, Toyomasa Katagiri, 中村 祐輔, 戸口田 淳也 and 坂井 義治 :
大腸癌進展におけるAFAP1L1遺伝子の関与,
69th Annual Meeting of the Japanese Cancer Association, Sep. 2010.
32. Toyomasa Katagiri, Tetsuro Yoshimaru, Taisuke Matsuo, 三好 康雄, 笹 三徳 and 中村 祐輔 :
Novel mechanism for activation of estrogen/estrogen-receptor signaling and novel therapeutic strategies in breast cancer,
69th Annual Meeting of the Japanese Cancer Association, Sep. 2010.
33. Park Jae-Hyun, Fukukawa Chikako, Toyomasa Katagiri and Nakamura Yusuke :
Identification of an O-type glycosyltransferase(GALNT6)as a nobel molecular target for breast cancer therapy,
69th Annual Meeting of the Japanese Cancer Association, Sep. 2010.
34. Taisuke Matsuo, Tetsuro Yoshimaru, 三好 康雄, 笹 三徳, 中村 祐輔 and Toyomasa Katagiri :
Identification and characterization of BCGT1 as a novel molecular target for breast cancer therapy,
69th Annual Meeting of the Lapanese Cancer Association, Osaka, Sep. 2010.
35. Fukukawa Chikako, Nishidate Toshihiko, Nakamura Yusuke and Toyomasa Katagiri :
Analysis of cell-growth promoting role of BGPRP in breast cancer,
69th Annual Meeting of the Japanese Cancer Assosiation, Sep. 2010.
36. Tetsuro Yoshimaru, Taisuke Matsuo, Miyoshi Yasuo, Sasa Mitsunori, Nakamura Yusuke and Toyomasa Katagiri :
Elucidating molecular-mechanism of triple-negative breast cancer through genome-wide gene-expression profile analysis,
69th Annual Meeting of the Japanese Cancer Association, Osaka, Sep. 2010.
37. Toyomasa Katagiri, Tetsuro Yoshimaru, Taisuke Matsuo, Miyoshi Yasuo, Sasa Mitsunori and Nakamura Yusuke :
Critical role of transactivation of ERAP1,estrogen receptor activity-regulated protein 1, in estrogen-dependent breast cancer cell growth,
The 6th International Symposium on Hormonal Carcinogenesisi in Japan, Sep. 2010.
38. Wataru Obara, Mitsugu Kanehira, Ryo Takata, Takuya Tsunoda, Koji Yoshida, Toyomasa Katagiri, Yusuke Nakamura and Tomoaki Fujioka :
Phase I clinical trial of novel HLA-A24 restricted DEPDC1 and MPHOSPH1 peptide vaccine for bladder cancer.,
8th Joint Conference of the American Association for Cancer Research and the Japanese Cancer Association, Waikoloa, Feb. 2010.
39. Harada Yosuke, Toyomasa Katagiri, Kanehira Mitsugu, Takata Ryo, Fujioka Tomoaki and Nakamura Yusuke :
Investigation of a novel potential therapeutic modality targeting to DEPDC1 for bladder cancer.,
8th Joint Conference of the American Association for Cancer Research and the Japanese Cancer Association, Waikoloa, Feb. 2010.
40. Ajiro Masahiko, Toyomasa Katagiri, Ueda Koji, Nakagawa Hidewaki, Nishidate Toshihiko, Fukukawa Chikako, Daigo Yataro and nakamura Yusuke :
Involvement of RQCD1 overexpression, a novel cancer-testis antigen, in breast cancer carcinogenesis though the regulation fo Akt activity,
8th Joint Conference of the American Association for Cancer Research and the Japanese Cancer Association, Waikoloa, Feb. 2010.
41. Toyomasa Katagiri and Yusuke Nakamura :
Critical role of transactivation of ERAP1, estrogen receptor activity-regulated protein 1, in estrogen-dependent breast cancer cells.,
8th Joint Conference of the American Association for Cancer Research and the Japanese Cancer Association, Waikoloa, Feb. 2010.
42. Nagayama Satoshi, Takahashi Ryo, Imoto Seiya, Furu Moritoshi, Toyomasa Katagiri, Nakamura Yusuke, Toguchida Junya and Sakai Yoshiharu :
Functional and immunohistochemical analyses of a novel protein upregulated in colorectal cancers.,
8th Joint Conference of the American Association for Cancer Research and the Japanese Cancer Association, Waikoloa, Feb. 2010.
43. Kim Jung-Won, Toyomasa Katagiri, Fukukawa Chikako, Daigo Yataro, Nishidate Toshihiko and Nakamura Yusuke :
Identification and characterization of BCUP2 as a novel molecular target for breast cancer therapy.,
8th Joint Conference of the American Association for Cancer Research and the Japanese Cancer Association, Waikoloa, Feb. 2010.
44. Fukukawa Chikako, Toyomasa Katagiri, Hanaoka Hirofumi, Nagayama Satoshi, Toguchida Junya, Yoshioka Hiroki, Endo Keigo and Nakamura Yusuke :
Development of antibody therapy against synovial sarcoma-targeting novel antigenidentified through analysis of genome-wide gene expression profile,
8th Joint Conference of the American Association for Cancer Research and the Japanese Cancer Association, Waikoloa, Feb. 2010.
45. Toyomasa Katagiri and Nakamura Yusuke :
Strategy for development of novel molecular-targeting drugs for breast cancer through gene-expression profile analysis,
Workshop Mexico-Japan "Genomic Medicine", Tokyo, Nov. 2009.
46. Nagayama Satioshi, Furu Moritoshi, Imoto Seiya, Takahashi Ryo, Kubo Hajime, Toyomasa Katagiri, Nakamura Yusuke, Toguchida Junya and Sakai Yoshiharu :
A novel recurrence predictor upregulated in colorectal cancers,
68th Annual Meeting of the Japanese Cancer Association, Yokohama, Oct. 2009.
47. Toyomasa Katagiri and Nakamura Yusuke :
Strategy for development of novel molecular-targeting drugs for breast cancer through gene-expression profile analysis,
68th Annual Meeting of the Japanese Cancer Association, Yokohama, Oct. 2009.
48. Park Jae-Hyun, Fukukawa Chikako, Nakamura Yusuke and Toyomasa Katagiri :
Identification and characterization of a novel therapeutic target with glycosylation activity in mammary carcinogenesis,
68th Annual Meeting of the Japanese cancer Association, Yokohama, Oct. 2009.
49. Harada Yosuke, Toyomasa Katagiri, Kanehira Mitsugu, Takata Ryo, Fujioka Tomoaki and Nakamura Yusuke :
Investigation of a novel potential therapeutic modality targeting to DEPDC1 for bladder cancer,
68th Annual Meeting of the Japanese cancer Association, Yokohama, Oct. 2009.
50. Ajiro Masahiko, Toyomasa Katagiri, Nishidate Toshihiko, Fukukawa Chikako, Daigo Yatoro and Nakamura Yusuke :
Characterazation of a novel therapeutic molecule, BCUP1 involved in mammary carcinogenesis,
68th Annual Meeting of the Japanese Cancer Association, Yokohama, Oct. 2009.
51. Kim Jung-Won, Toyomasa Katagiri, Fukukawa Chikako, Daigo Yatoro, Nishidate Toshihiko and Nakamura Yusuke :
Identification and characterization of BCUP2 as a novel molecular target for breast cancer therapy,
68th Annual Meeting of the Japanese Cancer Association, Yokohama, Oct. 2009.
52. Toyomasa Katagiri :
Identification of PBK/TOPK, Ser/Thr protein kinase as a druggable-target though analysis of genome-wide gene expression profile,
The 7th Sino-Japan Joint Conference for Cancer Research, Dec. 2008.
53. Toyomasa Katagiri and Nakamura Yusuke :

(International symposium, oral). Second JCA-AACR Special Joint Conference. The Latest Advances in Breast Cancer Research: From Basic Science to Therapeutics. Identification of PBK/TOPK, Ser/Thr protein kinase, as a druggable-target for breast cancer therapy though analysis of genome-wide gene expression profile. (International symposium, oral), Awaji-island, Jul. 2008.
54. C Fukukawa, Toyomasa Katagiri, H Hanaoka, S Nagayama, J Toguchida, K Endo and Y Nakamura :
Radioimmunotherapy for human synovial sarcoma xenografts with Yttrium 90-labeled anti-FZD10 monoclonal antibody,
Proceedings of the 99th Annual Meeting of the American Association for Cancer Research, San Diego, CA. Philadelphia (PA), Apr. 2008.
55. S Nagayama, M Furu, T Aoyama, H Kubo, G Watanabe, Toyomasa Katagiri and Y Nakamura :
Toguchida J, Sakai Y. Immunohistochemical analysis of a novel protein associated with the development of colorectal cancers,
Proceedings of the 99th Annual Meeting of the American Association for Cancer Research, San Diego, CA. Philadelphia (PA), Apr. 2008.
56. H Zembutsu, Y Suzuki, A Sasaki, T Tsunoda, T Hasegawa, DN Nikolova, LS Kee, Toyomasa Katagiri, K Hirata and Y Nakamura :
Predicting response to docetaxel neoadjuvant chemotherapy for advanced breast cancers through genome-wide gene expression profiling,
Proceedings of the 99th Annual Meeting of the American Association for Cancer Research, San Diego, CA. Philadelphia (PA), Apr. 2008.
57. K Ueda, Y Daigo, Y Fukase, Toyomasa Katagiri, N Ishikawa, S Irie, T Sato, N Kohno, M Shiwa and Y Nakamura :
A novel glycoproteomic approach for the discovery of carbohydrate-targeting serum tumor markers for lung cancer using Lectin-coupled ProteinChip system,
Proceedings of the 99th Annual Meeting of the American Association for Cancer Research, San Diego, CA. Philadelphia (PA), Apr. 2008.
58. J Park, Toyomasa Katagiri and Y Nakamura :
PBK/TOPK, a mitotic Ser/Thr kinase, is a novel druggable target for breast cancer therapy,
Proceedings of the 99th Annual Meeting of the American Association for Cancer Research, San Diego, CA. Philadelphia (PA), Apr. 2008.
59. Toyomasa Katagiri, M Lin, J Park and Y Nakamura :
Identification of MELK, Ser/Thr protein kinase, as a druggable-target for breast cancer therapy though analysis of genome-wide gene expression profile,
Proceedings of the 99th Annual Meeting of the American Association for Cancer Research, San Diego, CA. Philadelphia (PA), Apr. 2008.
60. S Dobashi, Toyomasa Katagiri, E Hirota, T Shuin, T Fujioka, T Miki and Y Nakamura :
Identification and characterization of RAPTM as a novel therapeutic target for renal cell carcinoma,
Proceedings of the 99th Annual Meeting of the American Association for Cancer Research, San Diego, CA. Philadelphia (PA), Apr. 2008.
61. J Kim, M Akiyama, Toyomasa Katagiri, T Nishidate and Y Nakamura :
Identification and characterization of ERAP1 as a novel molecular target for breast cancer therapy,
Proceedings of the 99th Annual Meeting of the American Association for Cancer Research, San Diego, CA. Philadelphia (PA), Apr. 2008.
62. Toyomasa Katagiri and Nakamura Yusuke :
Development of prediction system of response to M-VAC neoadjuvant chemotherapy for bladder cancer toward personalized medicine,
The 2007 EAUHGS symposium & the 7th EAUHGS Annual meeting, Changsha, Funan, China, Dec. 2007.
63. Toyomasa Katagiri and Nakamura Yusuke :
Development of prediction system of response to M-VAC neoadjuvant chemotherapy for bladder cancer,
7th Joint conference of the American association for cancer research and the Japanese cancer association, Jan. 2007.

Proceeding of Domestic Conference:

1. Keitaroh Anyohji, Keisuke Aihara, Tetsuro Yoshimaru, Yusuke Nishikawa, Masato Komatsu, Akira Shigenaga, Toyomasa Katagiri and Akira Otaka :
乳がん細胞におけるBIG3-PHB2相互作用を標的とした高持続性架橋ペプチドの開発,
日本薬学会第140年会, Mar. 2020.
2. Yosuke Matsushita, Masato Komatsu, Kazuma Kiyotani, Tetsuro Yoshimaru, 新沼 猛, 鈴木 拓, Junko Honda, Issei Imoto, Akira Tangoku, 三好 康雄, 笹 三徳 and Toyomasa Katagiri :
トリプルネガティブ乳癌の薬剤抵抗性に関与する新規癌抑制遺伝子SALL3の分子機構解明,
第1回日本癌学会若手の会, Feb. 2020.
3. Yosuke Matsushita, 高橋 定子, Masato Komatsu, Kazuma Kiyotani, Tetsuro Yoshimaru, 三好 康雄, Junko Honda, 粕谷 桂一, 大住 省三, 笹 三徳 and Toyomasa Katagiri :
全エキソーム解析による日本人家族性乳がん家系の新規感受性遺伝子の探索,
日本人類遺伝学会第64回大会, Nov. 2019.
4. Hitoshi Aibara, Tetsuro Yoshimaru, 尾野 雅哉, 笹 三徳, 三好 康雄 and Toyomasa Katagiri :
TNBC細胞のミトコンドリア制御における乳癌特異的分子BIG3の役割,
第78回日本癌学会学術総会, Sep. 2019.
5. Tetsuro Yoshimaru, Yosuke Matsushita, 笹 三徳, 三好 康雄 and Toyomasa Katagiri :
トラスツズマブ耐性乳がんに関連したBIG3-PHB2相互作用標的治療薬の開発,
第78回日本癌学会学術総会, Sep. 2019.
6. 加藤 廉平, Tomoya Fukawa, Yosuke Matsushita, Tetsuro Yoshimaru, 尾野 雅哉, Kei Daizumoto, 加藤 陽一郎, 小原 航 and Toyomasa Katagiri :
腎癌の癌化におけるPRELID2によるミトコンドリアROS制御機構の解明,
第78回日本癌学会学術総会, Sep. 2019.
7. Shun-ichi Toki, Tetsuro Yoshimaru, Yosuke Matsushita, Hitoshi Aibara and Toyomasa Katagiri :
骨肉腫細胞悪性化におけるBIG3の役割解明と分子間相互作用阻害ペプチド薬による抗腫瘍効果,
第78回日本癌学会学術総会, Sep. 2019.
8. Yosuke Matsushita, Kazumasa Okumura, Masato Komatsu, Ryuichiro Kimura, Tetsuro Yoshimaru, 尾野 雅哉, Junko Honda, Akira Tangoku, 三好 康雄, 笹 三徳 and Toyomasa Katagiri :
RHBDL2によるグルタミノリシスの制御はTNBCの悪性化や抗癌剤抵抗性に関連する,
第78回日本癌学会学術総会, Sep. 2019.
9. Toyomasa Katagiri :
乳がん細胞におけるO結合型糖鎖修飾を介した小胞体ストレス応答活性化機構の解明,
第38回日本糖質学会年会, Aug. 2019.
10. Toyomasa Katagiri :
無償な癌抑制因子を利用した新たなホルモン依存性乳癌治療薬の開発,
第20回ホルモンと癌研究会, Jun. 2019.
11. Toyomasa Katagiri and 水口 賢司 :
どれを標的にするか,どこを標的にするか?タンパク質間相互作用標的がん治療創薬を加速させる異分野融合,
第19回日本蛋白質科学会年会 第71回日本細胞生物学会大会 合同年次大会, Jun. 2019.
12. Keitaroh Anyohji, Keisuke Aihara, Tetsuro Yoshimaru, Akira Shigenaga, Toyomasa Katagiri and Akira Otaka :
がん抑制因子PHB2の部分配列を基盤とした乳がん阻害ペプチドの開発,
創薬懇話会2019 in 秋保, Jun. 2019.
13. Yosuke Matsushita, Masato Komatsu, Tetsuro Yoshimaru, 井本 逸成, 鈴木 拓 and Toyomasa Katagiri :
トリプルネガティブ乳癌におけるがん抑制因子SALL3の不活化機構の解明,
第23回日本がん分子標的治療学会学術集会, Jun. 2019.
14. Tetsuro Yoshimaru, Yosuke Matsushita and Toyomasa Katagiri :
BIG3複合体によるがん抑制因子PHB2の不活制化を介したトラスツズマブ耐性乳がんの増殖機構と新規治療法,
第23回日本がん分子標的治療学会学術集会, Jun. 2019.
15. Shun-ichi Toki, Tetsuro Yoshimaru, Yosuke Matsushita and Toyomasa Katagiri :
骨肉腫細胞悪性化におけるBIG3の役割解明と分子間相互作用阻害ペプチド薬による抗腫瘍効果の検討,
第23回日本がん分子標的治療学会学術集会, Jun. 2019.
16. Keitaroh Anyohji, Keisuke Aihara, Tetsuro Yoshimaru, Akira Shigenaga, Toyomasa Katagiri and Akira Otaka :
がん抑制タンパク質PHB2を基盤とした新規創薬シーズの開発,
日本薬学会第139年会, Mar. 2019.
17. Tetsuro Yoshimaru, Yosuke Matsushita and Toyomasa Katagiri :
新規Aキナーゼアンカータンパク質BIG3による抑制因子PHB2の制御はHER2乳癌細胞増殖に必須である,
第41回日本分子生物学会年会, Nov. 2018.
18. 高橋 定子, Yosuke Matsushita, Masato Komatsu, Kazuma Kiyotani, Tetsuro Yoshimaru, 本田 純子, 大住 省三, 笹 三徳 and Toyomasa Katagiri :
Identification and evaluation of novel susceptibility genes in Japanese familial breast cancer by whole exome sequencing,
第77回日本癌学会学術総会, Sep. 2018.
19. 加藤 廉平, Tomoya Fukawa, Tetsuro Yoshimaru, Yosuke Matsushita, 尾野 雅哉, Kei Daizumoto, 加藤 陽一郎, 小原 航 and Toyomasa Katagiri :
Critical roles of mitochondrial PRELID2 for renal carcinogenesis,
第77回日本癌学会学術総会, Sep. 2018.
20. Yosuke Matsushita, Masato Komatsu, Kazuma Kiyotani, Tetsuro Yoshimaru, 新沼 猛, 鈴木 拓, 本田 純子, Issei Imoto, Akira Tangoku, 三好 康雄, 笹 三徳 and Toyomasa Katagiri :
Downregulation of SALL3 by recurrent genetic and epigenetic alterations is involved in triple negative breast cancers,
第77回日本癌学会学術総会, Sep. 2018.
21. Kei Daizumoto, Tetsuro Yoshimaru, Yosuke Matsushita, Tomoya Fukawa, Hisanori Uehara, 尾野 雅哉, Masato Komatsu, Hiro-omi Kanayama and Toyomasa Katagiri :
Crucial roles of DDX31 as related to the status of TP53 in bladder cancer progression,
第77回日本癌学会学術総会, Sep. 2018.
22. Boya Deng, Yunus Tarhan Emre, Lili Ren, Ueda Koji, Toyomasa Katagiri, Jae-Hyun Park and Nakamura Yusuke :
Critical role of O-glycosylation of estrogen receptor alpha by GALNT6 in breast cancer cells,
The 77th Annual Meeting of the Japanese Cancer Association, Sep. 2018.
23. K.Li Huizi, Kanda Hiroaki, Nagayama Satoshi, Toyomasa Katagiri, Nakamura Yusuke and Hasegawa Sumitaka :
A novel therapeutic option for synovial sarcoma using alpha-radiolabeled FZD10 antibody,
The 77th Annual Meeting of the Japanese Cancer Association, Sep. 2018.
24. Tetsuro Yoshimaru, Yosuke Matsushita, 笹 三徳, 三好 康雄 and Toyomasa Katagiri :
BIG3-PKA-PP1Cα複合体による癌抑制因子PHB2不活性化を介したトラスツズマブ耐性乳癌増殖機構と新規治療法開発,
第77回日本癌学会学術総会, Sep. 2018.
25. Kazumasa Okumura, Yosuke Matsushita, Masato Komatsu, Ryuichiro Kimura, Tetsuro Yoshimaru, 尾野 雅哉, 三好 康雄, Junko Honda, 笹 三徳, Akira Tangoku and Toyomasa Katagiri :
Ritical pathophysiological roles of a potential therapeutic target RHBDL2 in triple negative breast cancer,
第77回日本癌学会学術総会, Sep. 2018.
26. Toyomasa Katagiri :
乳がん細胞における小胞体-ゴルジ体間シャトルを通じたIRE1活性化機構の解明,
第91会日本生化学会大会, Sep. 2018.
27. Keitaroh Anyohji, Keisuke Aihara, Tetsuro Yoshimaru, Akira Shigenaga, Toyomasa Katagiri and Akira Otaka :
がん 抑制タンパク質PHB2からの創薬シード発掘,
第50回若手ペプチド夏の勉強会, Aug. 2018.
28. Yosuke Matsushita, Masato Komatsu, Tetsuro Yoshimaru and Toyomasa Katagiri :
トリプルネガティブ乳がんの悪性化におけるRHBDL2の役割解明と創薬開発,
第22回日本がん分子標的治療学会学術集会, May 2018.
29. Kazumasa Okumura, 三好 康雄, Hirokazu Takechi, Junko Honda, 笹 三徳, Akira Tangoku and Toyomasa Katagiri :
《ポスター討議》トリプルネガティブ乳がんの悪性化におけるRHBDL2の役割解明,
第26回日本乳癌学会学術総会, May 2018.
30. Yosuke Matsushita, Masato Komatsu, Kazuma Kiyotani, Tetsuro Yoshimaru, 宮川 義仁, 本田 純子, Issei Imoto, Akira Tangoku, 鈴木 拓, 三好 康雄, 笹 三徳 and Toyomasa Katagiri :
Identification of recurrent genetic and epigenetic alterations in triple negative breast,
日本人類遺伝学会 第62回大会, Nov. 2017.
31. Tetsuro Yoshimaru, 尾野 雅哉, Yosuke Matsushita, Masato Komatsu, 笹 三徳, 三好 康雄 and Toyomasa Katagiri :
BIG3-PKA-PP1Cα複合体による癌抑制因子PHB2不活性化を介したエストロゲン依存性乳癌増殖機構と新規治療法開発,
第76回日本癌学会学術総会, Sep. 2017.
32. 高橋 定子, Yosuke Matsushita, Masato Komatsu, Tetsuro Yoshimaru, 本田 純子, 大住 省三, 三木 義男, Issei Imoto, 三好 康雄, 笹 三徳 and Toyomasa Katagiri :
日本人家族性乳がん家系の全エキソーム解析による新規家族性乳がん感受性遺伝子の同定,
第76回日本癌学会学術総会, Sep. 2017.
33. 井上 奈都子, 西向 有沙, 竹田 雅司, 盛本 浩二, 樋口 智子, 藤本 由希枝, 宮川 義仁, 荒木 和浩, 北島 一宏, 渡邊 隆弘, 廣田 誠一, Toyomasa Katagiri and 三好 康雄 :
乳癌においてglucose transporter-1の発現パターンはFDG-PETのSUVmax値と相関,
第76回日本癌学会学術総会, Sep. 2017.
34. Yosuke Matsushita, Masato Komatsu, Kazuma Kiyotani, Tetsuro Yoshimaru, 宮川 義仁, 本田 純子, Issei Imoto, Akira Tangoku, 三好 康雄, 笹 三徳 and Toyomasa Katagiri :
TNBCにおける包括的なゲノム解析によるZNFタンパク質のジェネティックかつエピジェネティックな変化の同定,
第76回日本癌学会学術総会, Sep. 2017.
35. 大豆本 圭, Tetsuro Yoshimaru, Tomoya Fukawa, Hisanori Uehara, 尾野 雅哉, Masato Komatsu, Hiro-omi Kanayama and Toyomasa Katagiri :
筋層浸潤性膀胱癌の多段階進展機構におけるDDX31, Mutant p53, EGFR Axisの役割解明,
第76回日本癌学会学術総会, Sep. 2017.
36. Kazumasa Okumura, Yosuke Matsushita, Masato Komatsu, Ryuichiro Kimura, Tetsuro Yoshimaru, 尾野 雅哉, 三好 康雄, Junko Honda, 笹 三徳, Akira Tangoku and Toyomasa Katagiri :
《Japanese Oral Sessions》トリプルネガティブ乳がんの悪性化におけるRHBDL2の役割解明,
第76回日本癌学会学術総会, Sep. 2017.
37. Ryuichiro Kimura, Taisuke Matsuo, 尾野 雅哉, Tetsuro Yoshimaru, Masato Komatsu, 本田 純子, 朴 在賢, 中村 祐輔, 笹 三徳, 三好 康雄 and Toyomasa Katagiri :
ムチン型糖転移酵素GALNT6はLGALS3BPの糖鎖修飾を通じて乳癌発症を制御する.,
第76回日本癌学会学術総会, Sep. 2017.
38. 加藤 廉平, Tomoya Fukawa, Tetsuro Yoshimaru, Yosuke Matsushita, 尾野 雅哉, 小原 航 and Toyomasa Katagiri :
腎癌の癌化におけるPRELID2の重要な役割,
第76回日本癌学会学術総会, Sep. 2017.
39. Toyomasa Katagiri :
ホルモン依存性乳がん治療の刷新を目指したがん抑制因子活性化による新規治療薬の開発,
第25回日本乳癌学会学術総会, Jul. 2017.
40. Toyomasa Katagiri :
新たなホルモン依存性乳がん治療薬の開発を目指して,
第42回日本外科系連合学会学術集会, Jun. 2017.
41. Tetsuro Yoshimaru, Yosuke Matsushita and Toyomasa Katagiri :
分子内架橋型BIG3-PHB2相互作用阻害ペプチドERAPによるホルモン依存性乳がん新規治療法の開発,
第21回日本がん分子標的治療学会学術集会, Jun. 2017.
42. Yosuke Matsushita, Masato Komatsu, Tetsuro Yoshimaru, 鈴木 拓, Issei Imoto and Toyomasa Katagiri :
全エクソームシーケンス解析によるトリプルネガティブ乳癌の分子特性の解明,
第21回日本がん分子標的治療学会学術集会, Jun. 2017.
43. Toyomasa Katagiri :
Regulation of estrogen/ estrogen receptor signallings in breast cancer cells,
11th International Symposium of The Institute Network ``Frontiers in Biomedical Sciences'', Jan. 2017.
44. Keisuke Aihara, Tetsuro Yoshimaru, Masato Komatsu, Akira Shigenaga, Toyomasa Katagiri and Akira Otaka :
Development of stapled peptides targeting BIG3-PHB2 interaction in breast cancer cells,
第53回ペプチド討論会, Oct. 2016.
45. Ryuichiro Kimura, 尾野 雅哉, Taisuke Matsuo, Tetsuro Yoshimaru, 三好 康雄, 笹 三徳 and Toyomasa Katagiri :
糖転移酵素GALNT6はガレクチン結合タンパク質1を糖鎖修飾し,乳癌発症を制御する,
第75回日本癌学会学術総会, Oct. 2016.
46. Tetsuro Yoshimaru, Yosuke Matsushita, Masato Komatsu, 岡崎 泰昌, 豊國 伸哉, 笹 三徳, 三好 康雄 and Toyomasa Katagiri :
内分泌療法耐性乳がんに対するBIG3-PHB2相互作用阻害ペプチドの開発,
第75回日本癌学会学術総会, Oct. 2016.
47. Toyomasa Katagiri :
Novel targeting therapeutic strategy for estrogen-dependent breast cancer,
第75回日本癌学会学術総会, Oct. 2016.
48. 瀧 亮祐, Tetsuro Yoshimaru, 大豆本 圭, Yosuke Matsushita, Ryuichiro Kimura, 尾野 雅哉 and Toyomasa Katagiri :
BIG3-PHB2相互作用を標的とした前立腺がん治療法の開発の可能性,
第75回日本癌学会学術総会, Oct. 2016.
49. Kazumasa Okumura, Masato Komatsu, Ryuichiro Kimura, 尾野 雅哉, Tetsuro Yoshimaru, Yosuke Matsushita, 三好 康雄, 本田 純子, 笹 三徳, Akira Tangoku and Toyomasa Katagiri :
トリプルネガティブ乳癌で高発現が認められるTNRHP1の発現亢進は癌の悪性度と相関する,
第75回日本癌学会学術総会, Oct. 2016.
50. Yosuke Matsushita, Masato Komatsu, Kazuma Kiyotani, Tetsuro Yoshimaru, 宮川 義仁, 本田 純子, Issei Imoto, Akira Tangoku, 三好 康雄, 笹 三徳 and Toyomasa Katagiri :
全エキソーム解析によるトリプルネガティブ乳癌の分子特性の解明,
第75回日本癌学会学術総会, Oct. 2016.
51. Toyomasa Katagiri :
滑膜肉腫に対するゲノム抗体創薬の現状と展望,
第49回日本整形外科学会 骨・軟部腫瘍学術集会, Jul. 2016.
52. Toyomasa Katagiri :
--,
構造活性フォーラム2016, Jun. 2016.
53. Toyomasa Katagiri :
がん細胞におけるゴルジ体-小胞体連携を介した小胞体ストレス応答制御機構,
第68回日本細胞生物学会大会 第11回日本ケミカルバイオロジー学会 合同大会, Jun. 2016.
54. Tetsuro Yoshimaru, Masato Komatsu and Toyomasa Katagiri :
--,
第20回日本がん分子標的治療学会学術集会, Jun. 2016.
55. Toyomasa Katagiri :
乳癌ゲノム研究の最前線∼包括的ゲノム解析によるトリプルネガティブ乳癌の分子特性の解明∼,
第12回日本乳癌学会関東地方会, Dec. 2015.
56. Namhee Kim, Tetsuro Yoshimaru, Toyomasa Katagiri and Eiji Tanaka :
乳がん細胞におけるがん抑制分子PHB2のエストロゲン依存性核内移行機序の解明,
第74回日本矯正歯科学会大会プログラム・抄録集, 194, Nov. 2015.
57. Toyomasa Katagiri, Masato Komatsu, Kazuma Kiyotani, Tetsuro Yoshimaru, Issei Imoto, 笹 三徳 and 三好 康雄 :
トリプルネガティブ乳癌における癌抑制遺伝子ZNFXの同定と不活化機構の解明,
日本人類遺伝学会第60会大会, Oct. 2015.
58. 井上 奈都子, 渡邊 隆弘, 廣田 誠一, Toyomasa Katagiri and 三好 康雄 :
乳癌における術前化学療法後のVimentin誘導と臨床効果の検討,
第74回日本癌学会学術総会, Oct. 2015.
59. 大豆本 圭, Masato Komatsu, Ryuichiro Kimura, Tetsuro Yoshimaru, Hisanori Uehara, 尾野 雅哉, Tomoya Fukawa, Hiro-omi Kanayama and Toyomasa Katagiri :
P53変異型膀胱癌におけるDEAD box polypeptide31(DDX31)の機能解明,
第74回日本癌学会学術総会, Oct. 2015.
60. 宮川 義仁, Masato Komatsu, Kazuma Kiyotani, Tetsuro Yoshimaru, 本田 純子, 笹 三徳, 三好 康雄 and Toyomasa Katagiri :
トリプルネガティブ乳癌における癌抑制遺伝子BCLR1の発現低下について,
第74回日本癌学会学術総会, Oct. 2015.
61. Tetsuro Yoshimaru, Masato Komatsu, 田代 悦, 長田 裕之, 井本 正哉, 豊國 伸哉, 三好 康雄, 笹 三徳 and Toyomasa Katagiri :
エストロゲン受容体制御分子BIG3を標的とした新規ER陽性乳がんの治療法,
第74回日本癌学会学術総会, Oct. 2015.
62. Toyomasa Katagiri :
エストロゲン受容体活性化制御分子BIG3を標的とした新たな乳癌治療薬の開発,
第23回日本乳癌学会学術総会, Jul. 2015.
63. Tetsuro Yoshimaru, Masato Komatsu, 田代 悦, 長田 裕之, 井本 正哉 and Toyomasa Katagiri :
エストロゲン受容体制御分子BIG3を標的とした新規ER陽性乳がん治療法の開発,
日本がん分子標的治療学会第19回学術集会, Jun. 2015.
64. Masato Komatsu, Tetsuro Yoshimaru, Issei Imoto and Toyomasa Katagiri :
トリプルネガティブ乳癌における新規腫瘍抑制遺伝子Zing finger protein-X(ZNFX)の不活化機構の解明,
日本がん分子標的治療学会第19回学術集会, Jun. 2015.
65. 大豆本 圭, Masato Komatsu, Tetsuro Yoshimaru, Hiro-omi Kanayama and Toyomasa Katagiri :
膀胱癌悪性化規定因子である新規核小体蛋白質DDX31の機能解析,
日本がん分子標的治療学会第19回学術集会, Jun. 2015.
66. Toyomasa Katagiri, Tetsuro Yoshimaru, Masato Komatsu, 田代 悦, 井本 正哉 and 長田 裕之 :
エストロゲン受容体制御分子BIG3を標的とした新規ホルモン依存性乳がん治療法の開発,
日本農芸化学会 2015年度(平成27年度)大会, Mar. 2015.
67. Toyomasa Katagiri, Tetsuro Yoshimaru and Masato Komatsu :
新規エストロゲンシグナル制御分子BIG3による新たながん抑制因子prohibitin2の機能喪失機構の解明,
第87回日本生化学学会大会, Oct. 2014.
68. 宮川 義仁, Masato Komatsu, Kazuma Kiyotani, Tetsuro Yoshimaru, 笹 三徳, 三好 康雄 and Toyomasa Katagiri :
トリブルネガティブ乳癌における癌抑制遺伝子BCLR1の発現低下について,
第73回日本癌学会学術総会, Sep. 2014.
69. Jiaying Lin, Jae-Hyun Park, Suyoun Chung, Koji Ueda, Toyomasa Katagiri, Koichi Matsuda and Yusuke Nakamura :
GALNT6 stabillizes GRP78 protein by O-type glycosylation and enhances its activity to suppress apoptosis under stress,
The 73rd Annual Meeting of the Japanese Cancer Association, Sep. 2014.
70. Namhee Kim, Tetsuro Yoshimaru, Masato Komatsu, Taisuke Matsuo, 笹 三徳 and Toyomasa Katagiri :
乳癌細胞における癌抑制分子PHB2のエストロゲン依存性核内移行機構の解明,
第73回日本癌学会学術総会, Sep. 2014.
71. Masato Komatsu, Tetsuro Yoshimaru, 尾野 雅哉, Taisuke Matsuo, Kazuma Kiyotani, 三好 康雄, 笹 三徳 and Toyomasa Katagiri :
悪性度の高いトリプルネガティブ乳癌における核内19S-proteasome関連遺伝子(nPAG1)の役割,
第73回日本癌学会学術総会, Sep. 2014.
72. Tetsuro Yoshimaru, Masato Komatsu, 三好 康雄, 笹 三徳 and Toyomasa Katagiri :
エストロゲン受容体制御分子BIG3を標的とした新規ER陽性乳がん治療法の開発,
第73回日本癌学会学術総会, Sep. 2014.
73. 高田 亮, 加藤 陽一郎, 前佛 均, Toyomasa Katagiri, 角田 達彦, 藤岡 知昭, 中村 祐輔 and 小原 航 :
網羅的遺伝子発現解析による筋層湿潤性膀胱がんのオーダーメイド医療,
第73回日本癌学会学術総会, Sep. 2014.
74. Toyomasa Katagiri :
がん特異的糖転移酵素による小胞体ストレス応答の恒常的活性化を標的とした新規創薬開発,
第73回日本癌学会学術総会, Sep. 2014.
75. 大豆本 圭, Masato Komatsu, Tetsuro Yoshimaru, Hisanori Uehara, Tomoya Fukawa, Hiro-omi Kanayama and Toyomasa Katagiri :
核小体がんタンパク質BCRG1は膀胱癌の進行に関連している,
第73回日本癌学会学術総会, Sep. 2014.
76. Toyomasa Katagiri :
包括的ゲノム解析を通じたトリプルネガティブ乳がんの分子特性,
第22回日本乳癌学会学術総会, Jul. 2014.
77. Masato Komatsu, Tetsuro Yoshimaru, Taisuke Matsuo and Toyomasa Katagiri :
トリプルネガティブ乳癌におけるプロテアソーム構成因子のプロテアソーム活性非依存的な役割,
第18回日本がん分子標的治療学会学術集会, Jun. 2014.
78. Tetsuro Yoshimaru, Masato Komatsu, Taisuke Matsuo and Toyomasa Katagiri :
エストロゲン受容体制御分子BIG3を標的とした新規ER陽性乳がんの治療法の創製,
第18回日本がん分子標的治療学会学術集会, Jun. 2014.
79. Toyomasa Katagiri :
泌尿器がん克服に向けた新規分子標的治療薬の開発の戦略,
第94回日本泌尿器科学会四国地方会, Jan. 2014.
80. Toyomasa Katagiri :
乳癌におけるゲノム解析研究の最前線,
第11回日本乳癌学会近畿地方会 特別講演, Nov. 2013.
81. Nakamura Toru, Toyomasa Katagiri, Nakagawa Hidewaki, Tsuchikawa Takahiro, Hirano Satoshi and Nakamura Yusuke :
Isolation and characterization of a novel gene as a therapeutic target for pancreatic cancer,
72nd Annual Meeting of the Japanese Cancer Association72, Oct. 2013.
82. Lo Hau Yi Paulisally, tanikawa Chizu, Toyomasa Katagiri, Nakamura Yusuke and Matsuda Koichi :
Identification of candidate tumor suppressor gene LBC1 in breast cancer,
72nd Annual Meeting of the Japanese Cancer Association, Oct. 2013.
83. Tetsuro Yoshimaru, Masato Komatsu, Taisuke Matsuo, 三好 康雄, 笹 三徳, 中村 祐輔 and Toyomasa Katagiri :
エストロゲン受容体活性化制御分子ERAP1と腫瘍抑制因子REAの相互作用を標的とした内分泌療法耐性乳癌の治療法の開発,
72nd Annual Meeting of the Japanese Cancer Association72, Oct. 2013.
84. Taisuke Matsuo, Ono Masaya, Tetsuro Yoshimaru, Masato Komatsu, Miyoshi Yasuo, Sasa Mitsunori and Toyomasa Katagiri :
がん特異的糖転移酵素BCGT1による小胞体ストレス制御を介した新規乳癌細胞増殖機構の解明,
72nd Annual Meeting of the Japanese Cancer Association, Oct. 2013.
85. Toyomasa Katagiri :
New insight into therapeutic strategies for acquired endocrine resistant breast cancer,
72nd Annual Meeting of the Japanese Cancer Association, Oct. 2013.
86. Yanai Ayako, Masato Komatsu, Tetsuro Yoshimaru, Kazuma Kiyotani, Ito Takashi, Hirota Seiichi, Sasa Mitsunori, Toyomasa Katagiri and Miyoshi Yasuo :
Molecular characteristics of ER-pisitive and HER2-negative breast cancer by immunohistochemistry,
72nd Annual Meeting of the Japanese Cancer Association, Oct. 2013.
87. Nagayama Satoshi, Takahashi Ryo, Imoto Seiya, Furu Moritoshi, Kajita Yoichiro, Toyomasa Katagiri, Nakamura Yusuke, Sakai Yoshiharu and Toguchida Junya :
Cytoskeleton-related protein C7059 is involved in the progression of colorectal cancer via regulation of cell migration,
72nd Annual Meeting of the Japanese Cancer Association, Oct. 2013.
88. Siew-Kee Low, Takahashi Atsushi, Kubo Michiaki, Toyomasa Katagiri and Nakamura Yusuke :
Genome-wide association study and pathway analysis for the genetic risk of breast cancer in japanese population,
72nd Annual Meeting of the Japanese Cancer Association, Oct. 2013.
89. Masato Komatsu, Tetsuro Yoshimaru, Taisuke Matsuo, Kazuma Kiyotani, Miyoshi Yasuo, Sasa Mitsunori and Toyomasa Katagiri :
Nuclear-19S proteasome associated gene 1 contributes to the aggressiveness of triple negative breast cancer cells,
72nd Annual Meeting of the Japanese Cancer Association, Oct. 2013.
90. 高田 亮, 加藤 陽一郎, 小原 航, 那須 崇志, 前佛 均, Toyomasa Katagiri, 中川 英刀, 角田 達彦, 久保 充明, 中村 祐輔 and 藤岡 知昭 :
Pharmacogenomics for Bladder and Prostate cancers,
72nd Annual Meeting of the Japanese Cancer Association, Oct. 2013.
91. ELGAZZAR Seham, Takahashi Norihiko, Yamaguchi Kiyoshi, Zembutsu Hitoshi, Toyomasa Katagiri, Ikenoue Tsuneo, Nakamura Yusuke and Furukawa Yoichi :
Identification of a single nucleotide polymorphism associated with SIAH2 Expression,
72nd Annual Meeting of the Japanese Cancer Association, Oct. 2013.
92. Toyomasa Katagiri :
トリプルネガティブ乳癌におけるプロテアソーム関連因子PAG1による新規増殖機構の解明,
第21回日本乳癌学会学術総会, Jun. 2013.
93. Taisuke Matsuo, Tetsuro Yoshimaru and Toyomasa Katagiri :
新規糖転移酵素BCGT1による小胞体ストレス応答制御を介した乳癌細胞増殖機構の解明,
第17回日本がん分子標的治療学会学術集会, Jun. 2013.
94. Masato Komatsu, Tetsuro Yoshimaru, Taisuke Matsuo, Nakamura Yusuke and Toyomasa Katagiri :
ゲノムワイドな網羅的遺伝子発現情報解析を用いたトリプルネガティブ乳癌(TNBC)の分子特性および新たな治療標的の探索,
第17回日本がん分子標的治療学会学術集会, Jun. 2013.
95. Tetsuro Yoshimaru, Masato Komatsu, Taisuke Matsuo and Toyomasa Katagiri :
ERα活性化制御分子ERAP1を標的とした内分泌療法耐性乳癌の治療戦略,
第17回日本がん分子標的治療学会学術集会, Jun. 2013.
96. Masato Komatsu, Tetsuro Yoshimaru, Taisuke Matsuo, Kazuma Kiyotani, 柳井 亜矢子 and Toyomasa Katagiri :
トリプルネガティブ乳癌におけるプロテアソーム関連因子PAG1による新規増殖機構の解明,
第246回 徳島医学会学術集会(平成24年度冬期), Feb. 2013.
97. Toyomasa Katagiri :
泌尿器がん克服に向けた新たな分子標的治療薬の開発戦,
第64回日本泌尿器科学会西日本総会, Nov. 2012.
98. Siew-Kee Low, Takahashi Atsushi, Seham Elgazzar, Kugo Michiaki, Toyomasa Katagiri and nakamura Yusuke :
Genome-wide association study of breast cancer in Japanese population,
The 71th Annual Meeting of the Japanese Cancer Association, Sep. 2012.
99. Nagayama Satoshi, Takahashi Ryo, Imoto Seiya, Furu Moritoshi, Kajita Yoichiro, Toyomasa Katagiri, Nakamura Yusuke, Sakai Yoshihayu and Toguchida Junya :
Functional analysis of a novel gene involved in the progression of colorecral cancers.,
The 71th Annual Meeting of the Japanese Cancer Association, Sep. 2012.
100. ELGAZZAR SEHAM, Zembutsu Hitoshi, Takahashi Atsushi, Kubo Michiaki, Aki Fuminori, Hirata Koichi, Takatsuka Yuichi, Okazaki Minoru, Ohsumi Shozo, Miki Yoshio, Sasa Mitsunori, Toyomasa Katagiri and Nakamura Yusuke :
A genome-wide association study identifies a locus associated with hormonal receptor positive breast cancer in Japanese,
The 71th Annual Meeting of the Japanese Cancer Association, Sep. 2012.
101. Kazuma Kiyotani, Fujimoto Akihiro, Masato Komatsu, Tetsuro Yoshimaru, Taisuke Matsuo, Tsunoda Tatsuhiko, Miyoshi Yasuo, Sasa Mitsunori and Toyomasa Katagiri :
Exome sequencing analysis of triple-negative breast cancer,
The 71th Annual Meeting of the Japanese Cancer Association, Sep. 2012.
102. Masato Komatsu, Tetsuro Yoshimaru, Taisuke Matsuo, Kazuma Kiyotani, Miyoshi Yasuo, Mitsuo Shimada, Nakamura Yusuke, Sasa Mitsunori and Toyomasa Katagiri :
Involvement of preteasome-associated gene 1(PAG1) in proliferation of triple negative breast cancer,
The 71th Annual Meeting of the Japanese Cancer Association, Sep. 2012.
103. Tetsuro Yoshimaru, Masato Komatsu, Taisuke Matsuo, Yasuo Miyoshi, Mitsunori Sasa, Yusuke Nakamura and Toyomasa Katagiri :
ERAP1 constitutively activates estrogen-signaling in ER-positive breast cancer by capturing intact tumor suppressor REA.,
The 71th Annual Meeting of the Japanese Cancer Association, Sep. 2012.
104. Tomoya Fukawa, Ono Masaya, Taisuke Matsuo, Hisanori Uehara, Nakamura Yusuke, Hiro-omi Kanayama and Toyomasa Katagiri :
RCCDH Regulates p53 Tumor suppressor activity in renal cell carcinomas.,
The 71th Annual Meeting of the Japanese Cancer Association, Sep. 2012.
105. Toyomasa Katagiri, Tetsuro Yoshimaru, Taisuke Matsuo, Nakamura Yusuke, Miyoshi Yasuo and Sasa Mitsunori :
New insight into developing treatment stategies for breast cacer,
The 71th Annual Meeting of the Japanese Cancer Association, Sep. 2012.
106. Deng Zhenzhong, Lin Jiaying, Tanikawa Chizu, Lo Hau Yi Paulisally, Toyomasa Katagiri, Daigo Yataro, Furukawa Hoichi, Nakamura Yusuke and Matsuda Koichi :
Screenting of expression profiles consisting of 783 cancer tissues identified TSRCC2 as a putative tumor suppressor gene,
The 71th Annual Meeting of the Japanese Cancer Association, Sep. 2012.
107. Lin Jiaying, Deng Zhenzhong, Lo Hau Yi Paulisally, Tanikawa Chizu, Toyomasa Katagiri, Nakamura Yusuke and Matsuda Koichi :
Genome-wide gene expression analyses identified TSRCC1 as a potential tumor suppressor gene of renall cell carcinoma,
The 71th Annual Meeting of the Japanese Cancer Association, Sep. 2012.
108. Taisuke Matsuo, Ono Masaya, Tetsuro Yoshimaru, Miyoshi Yasuo, Sasa Mitsunori, Nakamura Yusuke and Toyomasa Katagiri :
Regulation of endoplasmic reticulum stress response by a novel glycosyltransferase BCGT1 in breast cancer progrression,
The 71th Annual Meeting of the Japanese Cancer Association, Sep. 2012.
109. Le T. Dat, Taisuke Matsuo, Tetsuro Yoshimaru, Souji Kakiuchi, Hisatsugu Goto, Kuramoto Takuya, Mitsuhashi Atsushi, Saburo Sone, Yasuhiko Nishioka and Toyomasa Katagiri :
LBMTF a novel transcriptional factor involved in lung cancer bone metastases,
The 71th Annual Meeting of the Japanese Cancer Association, Sep. 2012.
110. Masato Komatsu, Tetsuro Yoshimaru, Taisuke Matsuo, Kazuma Kiyotani, 三好 康雄, Mitsuo Shimada, 中村 祐輔, 笹 三徳 and Toyomasa Katagiri :
Involvement of proteasome-associated gene 1 (PAG1) in proliferation of triple negative breast cancer. (トリプルネガティブ乳癌におけるプロテアソーム関連遺伝子PAG1を介した発癌・増殖機構の関与),
第71回 日本癌学会学術総会, Sep. 2012.
111. Toyomasa Katagiri :
遺伝子発現情報解析による乳癌治療標的分子の同定と新規治療戦略,
ファイザーオンコロジーフォーラム2011, Nov. 2011.
112. Le T. Dat, Taisuke Matsuo, Tetsuro Yoshimaru, Takuya Kuramoto, Masaki Hanibuchi, Hisatsugu Goto, Souji Kakiuchi, Yasuhiko Nishioka, Saburo Sone and Toyomasa Katagiri :
Genome-wide gene expression profiling analysis of bone metastases of human non-smal cell lung cancer (NSCLC) in mice,
70th Annual Meeting of the Japanese Cancer Association, Oct. 2011.
113. Komatsu Masato, Tetsuro Yoshimaru, Taisuke Matsuo, Miyoshi Yasuo, Mitsuo Shimada, Nakamura Yusuke, Sasa Mitsunori, Miyano Satoru and Toyomasa Katagiri :
Novel therapeutic strategy for Triple Negative Breast Cancer,
Proceedings of the Japanese Cancer Association, 237, Oct. 2011.
114. Toyomasa Katagiri :
新規エストロゲン依存性乳癌増殖機構の解明と新たな治療戦略,
第12回乳癌最新情報カンファランス, Aug. 2011.
115. Dat LeTan, Taisuke Matsuo, Hisatsugu Goto, Souji Kakiuchi, Yasuhiko Nishioka, Saburo Sone and Toyomasa Katagiri :
Identification and characterization of a novel transcription factor invoved lung cancer bone metastases,
第15回日本がん分子標的治療学会学術集会, Jun. 2011.
116. 小松 正人, Tetsuro Yoshimaru, Taisuke Matsuo, 中村 祐輔 and Toyomasa Katagiri :
Triple negative breast cancer(TNBC)における新規増殖シグナル経路および治療標的分子同定の試み,
第15回日本がん分子標的治療学会学術集会, Jun. 2011.
117. Tomoya Fukawa, Taisuke Matsuo, 中村 祐輔, Hiro-omi Kanayama and Toyomasa Katagiri :
腎細胞癌新規分子標的遺伝子RCCDPの同定およびその機能解析,
第15回日本がん分子標的治療学会, Jun. 2011.
118. Tomoya Fukawa, Taisuke Matsuo, 三木 恒治, 中村 祐輔, Hiro-omi Kanayama and Toyomasa Katagiri :
Identiffication and characterization of RCCMP as a novel molecular target for clear cell-renal cell carcinoma,
69th Annual Meeting of the Japanese Cancer Association, Sep. 2010.
119. Toyomasa Katagiri, Tetsuro Yoshimaru, Taisuke Matsuo, 三好 康雄, 笹 三徳 and 中村 祐輔 :
新規エストロゲン受容体活性化制御分子による乳癌細胞増殖機構の解明,
第11回ホルモンと癌研究会, Jul. 2010.
120. Tetsuro Yoshimaru, Taisuke Matsuo, Nakamura Yusuke and Toyomasa Katagiri :
新規エストロゲン受容体制御分子によるホルモン依存性乳がん増殖機構の解明,
第14回日本がん分子標的治療学会学術集会, Jul. 2010.
121. Taisuke Matsuo, 中村 祐輔 and Toyomasa Katagiri :
遺伝子発現情報解析を通じた新規エストロゲン受容体活性化制御分子ERAP1の同定とその機能解析,
第13回日本がん分子標的治療学会学術集会, Jun. 2009.
122. Toyomasa Katagiri and 中村 祐輔 :
最先端創薬システム:分裂期キナーゼTOPKを標的とした新規治療薬開発の戦略,
第13回日本がん分子標的治療学会学術集会, Jun. 2009.
123. 原田 陽介, 兼平 貢, 高田 亮, 藤岡 知昭, 中村 祐輔 and Toyomasa Katagiri :
膀胱癌新規治療標的分子DEPDC1の細胞増殖機構の解明,
第67回日本癌学会学術総会 ワークショップ, Oct. 2008.
124. 小原 航, 兼平 貢, 高田 亮, 角田 卓也, Toyomasa Katagiri, 中村 祐輔 and 藤岡 知昭 :
膀胱癌に対する新規腫瘍抗原遺伝子MPHOSPH1およびDEPDC1由来HLA-A24拘束性エピトープペプチドを用いた腫瘍特異的ワクチン療法,
第67回日本癌学会学術総会, Oct. 2008.
125. 林田 裕希, 生田 義明, 平田 真哉, 横峰 和典, 井上 光弘, 中面 哲也, Toyomasa Katagiri, 古川 洋一, 角田 卓也, 馬場 秀夫, 中村 祐輔, 佐々 木裕 and 西村 泰治 :
癌抗原SPARCを標的としたマウス癌免疫療法モデルの構築,
第67回日本癌学会学術総会, Oct. 2008.
126. 朴 在賢, 中村 祐輔 and Toyomasa Katagiri :
乳癌治療標的分子PBK/TOPKの細胞分裂における役割,
第67回日本癌学会学術総会 ワークショップ, Oct. 2008.
127. 網代 将彦, 西舘 敏彦, 醍醐 弥太郎, 富樫 亮, 中村 祐輔 and Toyomasa Katagiri :
乳癌における新規分子標的分子BCUP1の同定,
第67回日本癌学会学術総会 ワークショップ, Oct. 2008.
128. 金 正元, 秋山 未来, 西舘 敏彦, 醍醐 弥太郎, 富樫 亮, 中村 祐輔 and Toyomasa Katagiri :
乳癌治療新規分子標的候補遺伝子ERAP1の同定及びその機能解析,
第67回日本癌学会学術総会 ワークショップ, Oct. 2008.
129. 土橋 祥子, 廣田 英二, 執印 太郎, 藤岡 知昭, 三木 恒治, 醍醐 弥太郎, 中村 祐輔 and Toyomasa Katagiri :
腎癌治療に向けた新規分子標的治療候補遺伝子の探索ならびに機能解析,
第67回日本癌学会学術総会 ワークショップ, Oct. 2008.
130. 福川 千香子, 西舘 敏彦, 中村 祐輔 and Toyomasa Katagiri :
乳癌において発現上昇を認めるBGPRPの細胞増殖における役割,
第67回日本癌学会学術総会 ワークショップ, Oct. 2008.
131. 長山 聡, 布留 守敏, 青山 朋樹, 久保 肇, 渡辺 剛, Toyomasa Katagiri, 中村 祐輔, 戸口田 淳也 and 坂井 義治 :
大腸癌にて高発現している新規遺伝子の免疫組織化学染色による発現解析,
第67回日本癌学会学術総会 ワークショップ, Oct. 2008.
132. Hue Minh NGUYEN, Toyomasa Katagiri, 富樫 亮, 中村 祐輔 and 醍醐 弥太郎 :
肺癌,食道癌に関わる癌抗原LESTA1の道程と薬剤開発に向けた活性化機構の解析,
第67回日本癌学会学術総会 イングリッシュワークショップ, Oct. 2008.
133. 高田 亮, Toyomasa Katagiri, 加藤 陽一郎, 兼平 貢, 小原 航, 中村 祐輔 and 藤岡 知昭 :
膀胱癌の遺伝子発現プロファイル 基礎研究から臨床応用への取り組み,
第67回日本癌学会学術総会 ワークショップ, Oct. 2008.
134. Toyomasa Katagiri and Yusuke Nakamura :
遺伝子発現情報解析による乳癌新規治療標的分子の同定とその機能解析,
第67回日本癌学会学術総会 シンポジウム, Oct. 2008.
135. Toyomasa Katagiri and Nakamura Yusuke :
遺伝子発現情報解析による乳癌新規治療標的分子の同定とその機能解析,
第17回日本アポトーシス研究会・学術集会 シンポジウム, Aug. 2008.
136. Toyomasa Katagiri and Nakamura Yusuke :
FZD10モノクローナル抗体を用いた滑膜肉腫に対する抗体療法の検討,
第41回日本整形外科学会 骨・軟部腫瘍学術集会 シンポジウム, Jul. 2008.
137. Toyomasa Katagiri and 中村 祐輔 :
オーダーメイド医療の実現に向けた抗がん剤効果予測システムの開発,
日本薬学会128年会, Mar. 2008.
138. Toyomasa Katagiri and Nakamura Yusuke :
遺伝子発現情報解析を利用した乳癌新規治療薬分子標的候補遺伝子の同定およびその機能解析,
第66回日本癌学会学術総会 シンポジウム, Oct. 2007.
139. Toyomasa Katagiri and Nakamura Yusuke :
オーダーメイド医療実現化に向けた抗がん剤効果予測法の開発(特別講演),
第6回国際バイオEXPO&国際バイオフォーラムセミナー, Jun. 2007.
140. Toyomasa Katagiri :
滑膜肉腫分子標的治療を目的とした抗FZD10抗体の開発,
第3回日本癌学会カンファレンス(動物モデルによる新時代のがん研究-発症機構から治療まで), Mar. 2006.
141. Toyomasa Katagiri and 中村 祐輔 :
遺伝子発現解析に基づいた抗がん剤感受性予測システムの開発および分子標的薬候補遺伝子の解析(シンポジウム),
第2回日本癌学会カンファレンス(がんゲノム研究の新戦略-オーダーメイド医療を目指して), Mar. 2006.
142. Toyomasa Katagiri :
遺伝子発現解析に基づいた抗がん剤感受性予測,
第8回癌治療増感研究シンポジウム, Feb. 2006.
143. Toyomasa Katagiri and Nakamura Yusuke :
遺伝子発現情報解析によるがんのオーダーメイド治療,
第64回日本癌学会学術総会, Sep. 2005.
144. Toyomasa Katagiri :
乳癌および卵巣癌とBRCA1,
第13回日本がん検診・診断学会, Jul. 2005.
145. Toyomasa Katagiri and 中村 祐輔 :
泌尿器科癌における抗がん剤感受性予測システムの開発(シンポジウム),
第93回日本泌尿器学会, Apr. 2005.
146. Toyomasa Katagiri and 中村 祐輔 :
膀胱癌における遺伝子発現解析に基づいたMVAC療法感受性予測システムの開発および分子標的候補遺伝子の解析(特別講演),
第14回泌尿器科分子細胞研究会, Feb. 2005.
147. Toyomasa Katagiri and 中村 祐輔 :
オーダーメイド医療実現に向けてのイマチニブ感受性予測システムの開発(シンポジウム),
第51回臨床検査医学会総会・第44回臨床化学会年会連合大会, Sep. 2004.
148. Toyomasa Katagiri and 中村 祐輔 :
オーダーメイド医療実現に向けての抗がん剤感受性予測システムの開発(シンポジウム),
BioJapan 2004, Sep. 2004.
149. Toyomasa Katagiri and 中村 祐輔 :
オーダーメイド医療実現に向けての抗がん剤感受性予測システムの開発(シンポジウム),
ゲノム創薬フォーラム, Jul. 2004.
150. Masato Komatsu, Tetsuro Yoshimaru, Taisuke Matsuo and Toyomasa Katagiri :
--,
第18回日本がん分子標的治療学会学術集会, Jun. 2004.
151. Toyomasa Katagiri and 中村 祐輔 :
オーダーメイド医療実現に向けての抗がん剤感受性予測システムの開発(シンポジウム),
がん分子標的治療研究会, May 2004.
152. Toyomasa Katagiri and 中村 祐輔 :
遺伝子発現解析に基づいた抗がん剤感受性予測(シンポジウム),
第62回日本癌学会学術総会, Sep. 2003.
153. Toyomasa Katagiri and 中村 祐輔 :
白血病細胞に対する遺伝子発現プロファイル解析(シンポジウム),
第61回日本癌学会学術総会, Sep. 2002.

Et cetera, Workshop:

1. Toyomasa Katagiri :
治療抵抗性乳がんに対する治療薬の開発,
あけぼの徳島乳がん講演会, Dec. 2019.
2. Toyomasa Katagiri :
治療耐性克服に向けた革新的乳がん治療薬の開発を目指して,
香川大学創立70周年記念事業 第14回医農連携セミナー, Nov. 2019.
3. Toyomasa Katagiri :
四国遺伝性乳がん研究会からの新しい遺伝性乳がんの原因遺伝子の発見に向けた取り組み,
あけぼの徳島乳がん講演会, Dec. 2018.
4. Toyomasa Katagiri :
乳がんの遺伝子診断の最前線,
第22回武庫川Breast Cancer Seminar, Oct. 2018.
5. Toyomasa Katagiri :
がんの正体∼ゲノムから紐解く,食品との関係性∼,
岡山県食品新技術応用研究会 第342回研修会特別講演, May 2018.
6. Toyomasa Katagiri :
乳がん治療刷新を目指したがん抑制因子活性化による新規治療薬の開発,
2nd TRS exgend Translational Research School, May 2018.
7. Toyomasa Katagiri :
がん抑制因子活性化を利用した新規乳がん治療薬の開発,
KOBR研究会, Jan. 2018.
8. Toyomasa Katagiri :
--,
あけぼの徳島 乳がん講演会, Dec. 2017.
9. Toyomasa Katagiri :
泌尿器がんの悪性進展化制御機構の解明と治療展開,
第12回Basic Urology Research Seminar, Aug. 2017.
10. Toyomasa Katagiri :
がんゲノム医療の現状と実現にむけて,
第15回兵庫医科大学がんセンター講演会, Mar. 2017.
11. Toyomasa Katagiri :
包括的ゲノム解析を通じたトリプルネガティブ乳がんの分子特性の解明∼トリプルネガティブ乳がんという分類をなくす∼,
第14回武蔵野乳癌研究会, Mar. 2017.
12. Toyomasa Katagiri :
--,
あけぼの徳島 乳がん講演会, Nov. 2016.
13. Toyomasa Katagiri :
乳癌における新規エストロゲンシグナル制御機構の解明と新規治療薬の開発,
第1回徳島大学神戸大学連携シンポジウム, Sep. 2016.
14. Toyomasa Katagiri :
--,
第7回阪神乳癌カンファレンス, May 2016.
15. Toyomasa Katagiri :
--,
Breast Cancer Expert Meeting in TOKYO 2016, May 2016.
16. Yosuke Matsushita and Toyomasa Katagiri :
--,
キアゲンバイオインフォマティクスユーザーグループミーティング, May 2016.
17. Yosuke Matsushita, Masato Komatsu, Kazuma Kiyotani, Tetsuro Yoshimaru, 宮川 義仁, 本田 純子, Issei Imoto, Akira Tangoku, 三好 康雄, 笹 三徳 and Toyomasa Katagiri :
--,
第75回徳島乳腺研究会, Apr. 2016.
18. Toyomasa Katagiri :
--,
第5回 Translational Research Conference, Mar. 2016.
19. Toyomasa Katagiri :
ゴルジ体-小胞体間ストレス応答活性化によってもたらされる癌細胞増殖機構の解明,
第10回小胞体ストレス研究会, Nov. 2015.
20. Toyomasa Katagiri :
--,
あけぼの徳島 乳がん講演会, Nov. 2015.
21. Toyomasa Katagiri :
がんを知り,がんに挑む-最新がんゲノム情報,
リレー・フォー・ライフ・ジャパン2015とくしま 講演会, Oct. 2015.
22. Toyomasa Katagiri :
がん抑制因子活性化による内分泌療法耐性乳がんに対する新規治療薬の開発,
TPCシリーズセミナー∼乳がん研究の最前線∼, Sep. 2015.
23. Toyomasa Katagiri :
エストロゲンシグナル制御分子BIG3を標的とした新規乳がん治療戦略,
第796回千葉県がんセンター研究所集談会, Aug. 2015.
24. Toyomasa Katagiri :
泌尿器科がんの克服に向けた新規分子標的抗がん剤の開発戦略,
第519回岩手泌尿器科懇話会, Jun. 2015.
25. Toyomasa Katagiri :
--,
徳島県生活習慣病管理指導協議会 乳がん部会 乳がん検診従事者講習会, Mar. 2015.
26. Toyomasa Katagiri :
--,
あけぼの徳島 乳がん講演会, Nov. 2014.
27. Toyomasa Katagiri :
--,
第12回関東骨軟部腫瘍の基礎を語る会, Oct. 2014.
28. Toyomasa Katagiri :
日本の医学研究を考える∼サバイバーと研究者の連携をめざし,
リレー・フォー・ライフ・ジャパン福岡 講演会, Sep. 2014.
29. Ryuichiro Kimura, Tetsuro Yoshimaru, Masato Komatsu, 三好 康雄, 笹 三徳 and Toyomasa Katagiri :
トリプルネガティブ乳癌の発症・進展におけるBIG3の役割,
平成26年度がん若手研究者ワークショップ, Sep. 2014.
30. Toyomasa Katagiri :
--,
がん分子標的治療, Aug. 2014.
31. Toyomasa Katagiri :
乳癌における小胞体ストレス応答活性化制御機構の解明,
第9回小胞体ストレス研究会, Jul. 2014.
32. Toyomasa Katagiri :
--,
リレーフォーライフジャパンサミット2013, Feb. 2014.
33. Toyomasa Katagiri :
--,
徳島大学大学院市民公開講座/中国・四国広域がんプロ養成コンソーシアム, Jan. 2014.
34. Toyomasa Katagiri :
網羅的遺伝子発現解析による乳がん特異的エストロゲンシグナル制御分子の同定と革新的治療法の開発,
乳腺勉強会, Nov. 2013.
35. Toyomasa Katagiri :
--,
あけぼの徳島 乳がん講演会, Nov. 2013.
36. Toyomasa Katagiri :
乳癌における小胞体ストレス応答活性化制御機構の解明,
第8回小胞体ストレス研究会, Oct. 2013.
37. Toyomasa Katagiri :
新たな乳がんホルモン治療薬の開発について,
リレー・フォー・ライフ・ジャパン大分 講演会, Sep. 2013.
38. Tetsuro Yoshimaru, 石田 真由美 and Toyomasa Katagiri :
Elucidation of novel biological functions of Estrogen Receptor Activity-regulated Protein 1 in refractory breast cancer,
平成25年度がん若手研究者ワークショップ, Sep. 2013.
39. Toyomasa Katagiri :
ゲノム解析によるがん研究,
平成26年度 第35回洲本市健康大学講座, Jul. 2013.
40. Toyomasa Katagiri :
最新の乳がん基礎研究,
あけぼの徳島 乳がん講演会, Nov. 2012.
41. Toyomasa Katagiri :
内分泌療法抵抗性乳がん克服に向けた新規エストロゲンシグナル制御機構の解明,
慶応義塾大学理工学部生命情報学セミナー, Oct. 2012.
42. Toyomasa Katagiri :
リレー・フォー・ライフ かごしま 2012 対談講演,
Sep. 2012.
43. Masato Komatsu, Tetsuro Yoshimaru, Taisuke Matsuo, Kazuma Kiyotani, 斉藤 あゆむ, 山口 類, 宮野 悟, 三好 康雄, 笹 三徳, 中村 祐輔 and Toyomasa Katagiri :
Involvement of 26S proteasome-associated genes in carcinogenesis of triple negative breast cancer,
平成24年度がん若手研究者ワークショップ, Sep. 2012.
44. Toyomasa Katagiri :
新しいホルモン依存性乳がんの細胞増殖機構の発見と新規治療薬開発を目指して,
九州大学農学部 生命機能科学部門セミナー, Jun. 2012.
45. Toyomasa Katagiri :
がん患者が語るそれぞれのがん ワクチン療法をもっと知りたい.,
NPO法人AWAがん対策募金, Jun. 2012.
46. Toyomasa Katagiri :
医科学におけるオミックス研究,
2012東京大学医科学研究所大学院セミナー, Jun. 2012.
47. Toyomasa Katagiri :
乳がんにおける新規エストロゲンシグナル制御機構の解明と治療戦略,
第19・20回愛媛大学医学部分子病態医学セミナー, Feb. 2012.
48. Toyomasa Katagiri :
乳がんはなぜおこるの?-遺伝子の異常と乳がん-,
あけぼの徳島 乳がん講演会, Nov. 2011.
49. Toyomasa Katagiri :
リレー・フォー・ライフ ジャパン とくしま 2011 対談講演,
Oct. 2011.
50. Taisuke Matsuo, 尾野 雅哉, Tetsuro Yoshimaru, 三好 康雄, 笹 三徳, 中村 祐輔 and Toyomasa Katagiri :
Identification of characterization of a novel glycosyltrasnferase BCGT1 involved in breast cancer cells,
平成23年度がん若手研究者ワークショップ, Sep. 2011.
51. Toyomasa Katagiri :
ヒトゲノム情報のがん医療への応用,
平成21年度第2回データベース講習会@四国「疾患研究のためのゲノム情報の活用」, Nov. 2009.
52. Toyomasa Katagiri :
これからの新薬,
あけぼの会 乳がん講演会「乳がんといわれたら∼乳がん治療薬の最前線∼」, Oct. 2009.
53. Toyomasa Katagiri :
遺伝子発現解析に基づいた乳がん新規治療標的分子の同定および機能解析,
独立行政法人医薬基盤研究所 セミナー, Oct. 2009.
54. Toyomasa Katagiri :
遺伝子発現情報解析に基づいた膀胱がん治療戦略,
第11回泌尿器疾患ゲノム解析研究会, Mar. 2009.
55. Toyomasa Katagiri :
ゲノム情報解析に基づいた乳癌治療標的分子の同定と治療薬開発の試み,
第3回武庫川 Breast Cancer Seminar, Feb. 2009.
56. Toyomasa Katagiri :
ゲノム情報解析に基づいた乳癌分子標的治療薬開発にむけて,
大塚製薬株式会社藤井記念研究所学術講演, Feb. 2009.
57. Toyomasa Katagiri :
--,
あけぼの徳島 乳がん講演会, Nov. 5.

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)

  • Elucidating mechanisms of therapeutic resistance in breast cancer and the development of innovative therapeutic approach utilizing tumor suppressor activity (Project/Area Number: 20H00543 )
  • 非アルコール性脂肪肝炎における肝再生機能不全の解明と統合的治療法の開発 (Project/Area Number: 18H02871 )
  • Drug discovery in breast cancer utilizing reactivation of tumor suppressors (Project/Area Number: 17K19601 )
  • 小胞体品質管理に関わる選別輸送ゾーンの解明 (Project/Area Number: 17H06419 )
  • 新たなエストロゲン依存性乳癌の多段階発癌機構のシステム的統合理解 (Project/Area Number: 16H01575 )
  • Clarification of novel pathophysiological roles of BIG3 in breast cancer cells (Project/Area Number: 16H05153 )
  • Therapeutic advances in BIG3-PHB2 inhibition targeting the cross-talk between estrogen and growth factors in breast cancer (Project/Area Number: 26461948 )
  • Development of multidisciplinary therapy for aged liver insufficiency based on the mechanism of hepatic stellate cell dysfunction. (Project/Area Number: 26293288 )
  • 内分泌療法耐性乳癌克服に向けた新規エストロゲンシグナル制御のシステム的統合理解 (Project/Area Number: 25134712 )
  • Identification and characterization of a novel unknown glycosyltransferase GTUF in breast cancer cells (Project/Area Number: 25860240 )
  • Drug development and biological function study of novel estrogen receptor activity modulator BIG3 protein (Project/Area Number: 25293079 )
  • 新規エストロゲン依存性乳癌細胞増殖機構のシステム的統合理解 (Project/Area Number: 23134504 )
  • Functional roles of a novel glycosyltrasnferase BCGT1 in breast cancer cells (Project/Area Number: 23790369 )
  • Development of multidisciplinary therapy based on mechanism of liver insufficiency in a use of Aged partial graft after liver transplantation. (Project/Area Number: 23390324 )
  • 有効な腫瘍マーカーのない婦人科悪性腫瘍に対する新しい腫瘍マーカーの確立 (Project/Area Number: 20014024 )
  • Search by Researcher Number (60291895)